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1Preclinical and clinical study on Rajarajeswaram and
Madhanabiravam for anti- epileptic activity in the management
of Valippu(Epilepsy)
INTRODUCTION:
Siddha system which is widely practiced in Tamilnadu,it is one of the most
ancient medical system in the world. Siddhars classified diseases into 4448 types. The
raw materials used for treating diseases by the Siddhars as drugs were classified into
herbal, herbo-mineral, metal, inorganic,animal products and sea products. Discreption
of the disease Valippu noi(Epilepsy) was taken for this research had already described
by siddhars about the types ,symptoms and treatment methodology.
 Epilepsy is a neurological disorder due to sudden burst of abnormal electrical
discharges from the brain. Epilepsy is the second most common chronic neurological
condition seen by neurologists. It has no age, racial, social, sexual or geographical
boundaries.
Epilepsy affects 50 million people worldwide, and 80% of them live in the
developing world. It is estimated that there are 55,00,000 persons with epilepsy in
India. 3-5%of the population have a seizure sometime in their life and 0.5%-1%of the
population have ‘active epilepsy’.
Epilepsy treatment responds to nearly 70% of patients, but in developing
countries, three-fourths of people with epilepsy are ignorant to receive the essential
treatment. In the modern medicine system anti-epileptic medicines are unaffordable,
need long term medication and are having more contra-indications like sedation,
mental irritation, memory loss, obesity, lethargy, poor concentration, inflammation of
gums, etc. And for these above reasons, epileptic patients find it difficult to follow.
Evaluation of prevalence study indicates that more case-control studies to find out
the aetiology, pharmaco-economic study to find out the affordable drug for
general public and mass health education should be undertaken to dispel the social
stigma and to bring about change in the attitude about the disease.
But several hundred years ago itself in the siddha system of medicine, siddhars,
like Agasthiyar, found out the right diagnosis of epilepsy and proper treatment . They
classified the epilepsy in to 21 types and prescribed siddha medicines for the same.
2As per the literature Agasthiyar Vaidhya Chinthamani the symptoms of kakkai
valippu are mentioned as giddiness followed by a fall with huge cry, syncope and
involuntary movements of both legs and arms. As per Sarabendrar Vadha Roga
Chigichai the symptoms are as follows “Tremors in both arms and legs followed by
syncope, involuntary rotation of eye balls”. According to T.V. Saambasivam Pillai
Dictionary Kakkai Valippu is defined as “It is a disease of central nervous system
characterised by uttering a strangled scream, loss of consciousness, white froths
collecting on the lips and other distressing features of a dying person”.In review of
siddha text, Onan sudar thylam, Gandhaga sudar thylam, Jothi rishi thylam,Veepam
nei and Pitchu ennai are found to be suitable medicines now prescribed by the siddha
physicians for the management of epilepsy. To cite an example, in Tiruvannamalai
District, in Madavalam village oil called Valippu ennai is given for the epileptic
patients and this is the traditional treatment being followed for a long period of time.
For better convenience of the patient rather than oil, the scholar had prefered
Rajarajeswaram and Madhana biravam tablets, and hence, chosen this subject for
the dissertation work. Both the above mentioned tablets are indicated for Janni noi in
Siddha vaidiya thirattu, authored Dr.K.N.Kuppusamy mudaliyar and
Dr.K.S.Uhuthamarayan, published by Department of Indian medicine and
Homeopathy, Govt of Tamilnadu. Seizure is one among the primary symptom of
janni noi. Janni and valippu are with predominant elevation of iya kutram. These
tablets contains the ingredients like minerals found in the above said of oil, and
pitchi(bile) found in the oil meant for children. Hence the Rajarajeswarm and
Madhana biravam were chosen as the trial drugs and these tablets have not been
evaluated for anti- epileptic activity so far. Hence the study has been selected for the
scientific evaluation of the trial drugs and the therapeutic efficacy in treating epilepsy.
3AIM AND OBJECTIVES
AIM
To evaluate the safety and efficacy of Rajarajeswaram and Madhana biravam for anti-
epileptic activity in the management of Epilepsy.
OBJECTIVES
The pre-clinical and clinical efficacy of Rajarajeswaram and Madhana biravam have been
evaluated in the following aspects.
1. Review of literature.
2. Standard operative procedure
3. Bio-chemical aspect
4. Quantitative analysis and physical properties.
5. Atomic absorption spectrophotometer (AAS) for chemical characterization.
6. FTIR study.
7. SEM analysis
8. Toxicological study:
Acute toxicity and sub-acute toxicity
9. Pharmacological study:
Anti-epileptic activity
10. Clinical study:
A pilot study on Rajarajeswaram and Madhana biravam.
11. Statistical analysis.
4REVIEW OF LITERATURE
Ingredients of the trial drug 1: Rajarajeswaram*
The following raw drugs are the ingredients of Rajarajeswaram
Rasam (Mercury) - 35 gms.
Paal Thutham(Zinc sulphate) - 35 gms.
Lingam(Chinnabar) - 35 gms.
Gandagam(Sulphur) - 35 gms.
Manosilai(Red orpiment) - 35 gms.
Nabi(Aconitum ferox.Linn) - 35 gms.
Vepam eerku kudineer(Azadirachta indica.A.Juss) - 35 gms.
Pichu(Goat and he-buffalo bile) - sufficient quantity.
Ingredients of the trial drug 2:( Madhana biravam)*
The following raw drugs are the ingredients of Madhana biravam
Rasam (Mercury) - 35 gms.
Gandagam(Sulphur) - 35 gms.
Manosilai(Red orpiment) - 35 gms.
Indhuppu(Sodium chloride impura) - 35 gms.
Tamira parpam (Copper parpam) - 35 gms.
Kandakathiri pazha saaru(solanum surattense Burm.f) - 35 gms.
Pichu(Cow Bile) - sufficient quantity.
* Siddha vaidiya thirattu, authored Dr.K.N.Kuppusamy mudaliyar and Dr.K.S.Uhuthamarayan, published by Department
of Indian medicine and Homeopathy, Govt of Tamilnadu.
5NAABI
English Name : Indian aconite
Common names  : Indian aconite, monks hood, blue aconite
Botanical Name  : Aconitum ferox. Linn
Family : Rananculaceae
Distribution : Blue aconite is found in Nepal, Kashmir, Sikkim, Bhutan
at altitudes of 2000-3000 meters. It is a typical Himalayan plant and has even been
observed growing at 3600 meters.
Organoleptic characters:
Taste : Bitter
Potency : Hot
Pirivu : Acrid
Actions: Diaphoretic,Diuretic,Anti-periodic,Anodyne,Anti-phlogistic,Narcotic,Sedative .
The root is attributed with sweat, nervine, appetite stimulatory, calming and anti-pyretic
effects.
:
“Å¡¾ÅÄ¢ Áó¾ÁÈø Á¡È¡ì ¸ÀôÀ¢½¢¸û
µÐÌð¼ ÌýÁó §¾÷ ´Îí¸¡ñ - ¸¡¾Ä÷¾õ
Òò¾¢§Â¡ ¼¡ÕÂ¢Õõ â×õ Å¨ÉÌÆ§Ä!
Íò¾¢ ¦ºö¾ ¿¡À¢Â¢ý§À÷ ¦º¡ø”.
Phyto-chemicals: Aconite root contains 0.3 to 1 percent of alkaloids like Aconitine
which is crystalline, acrid and highly toxic, Benzaconine (Picraconitine) and Aconine
Uses:Internally tincture of root is used in treating fever and rheumatism. Paste of root is
applied externally in case of neuralgia, rheumatism, acute gout and painful conditions.
6REPORTED PHARMACOLOGICAL ACTIVITIES:
Inhibition of stimulus-triggered and spontaneous epileptiform activity in rat
hippocampal slices by the Aconitum alkaloid mesaconitine.
Abstract
The aim of the present study was to investigate if the plant alkaloid, mesaconitine,
which has been reported to have antinociceptive effects via stimulation of the
noradrenergic system, inhibits epileptiform field potentials. The experiments were
performed as extracellular recordings on rat hippocampal slices. Spontaneous
epileptiform activity was elicited by perfusing a nominally Mg2+-free bathing medium
with high K+ concentration (5 mM). Both stimulus-triggered and spontaneous
epileptiform activity was attenuated in a concentration-dependent manner by
mesaconitine (30 nM-1 microM). The inhibitory effect was rather variable in appearance
when lower concentrations (30 and 100 nM) of mesaconitine were applied. Pretreatment
of the slices with the alpha-adrenoceptor antagonist yohimbine (1 microM) prevented the
effect of mesaconitine. It is concluded that the inhibitory action of mesaconitine at low
concentration is mediated via alpha-adrenoceptors.
Bicuculline-induced epileptiform activity in rat hippocampal slices: suppression
by Aconitumalkaloids.
Abstract
Alkaloids of Aconitum spec. (Ranunculaceae) are employed in traditional Chinese
folk medicine as analgesics. The present study was designed in order to investigate the
effects of the structurally related alkaloids aconitine, lappaconitine, and 6-
benzoylheteratisine on experimentally induced epileptiform activity. Experiments were
performed as extracellular recordings of stimulus evoked population spikes in rat
hippocampal slices.. The present findings suggest that the structurally
related Aconitum alkaloids aconitine, lappaconitine, and 6-benzoylheteratisine possess an
anticonvulsive potential. The predominant effect of these alkaloids is to suppress the
spread of seizure activity, and they may therefore tend to distort epileptic events.
However, despite their similar structure, they exert qualitatively and quantitatively
different inhibitory effects.
7The effects of Aconitum alkaloids on the central nervous system.
Abstract
Preparations of Aconitum roots are employed in Chinese and Japanese medicine
for analgesic, antirheumatic and neurological indications. The recent surge in use of
phytomedicine derived from traditional Chinese medicine as well as increasing concerns
about possible toxic effects of these compounds have inspired a great deal of research into
the mechanisms by which certain Aconitum alkaloids may act on the central nervous
system. The pharmacological effects of preparations of Aconitum roots are attributed to
several diterpenoid alkaloids. The main alkaloid of these plants is aconitine, a highly
toxic diterpenoid alkaloid which is known to suppress the inactivation of voltage-
dependent Na+ channels by binding to neurotoxin binding site 2 of the alpha-subunit of
the channel protein.
Aconitine inhibits epileptiform activity in rat hippocampal slices.
Abstract
The effect of aconitine, an alkaloid neurotoxin known to bind at site 2 of the
sodium channel, was investigated on epileptiform activity in hippocampal slices by use of
extracellular recordings in CA1 pyramidal cell layer. Epileptiform activity was induced
by bicuculline, picrotoxin, penicillin, pentylenetetrazol or by omission of magnesium
from the bathing medium, respectively. In every case aconitine (0.1 and 1 microM)
blocked the multiple population spikes representing the epileptiform activity. The onset of
inhibition was shorter by use of an increased concentration of the epileptogenic drug.
Epileptiform activity evoked by pentylenetetrazol and low magnesium was first increased
by aconitine followed by a rapid inhibition, while the bicuculline-, picrotoxin-, and
penicillin-induced epileptiform discharges were immediately abolished
8RASAM
English name : Mercury, Quick Silver
Chemical name : Hydrar gyrum
Organoleptic Characters
Taste : Six tastes – dominated by sweet
Potency : Hot and Cold
Actions : Tonic, Vitalizer, Diuretic, Silogogue, Anti inflammatory,
Laxative,
Neutralizing pitha, Medicine for venereal diseases.
The Mercury is the chief of all elements. It gives good health, protects the body
and cures the diseases that affect the body. Further it facilitates to attain the
eight folded siddhis.
:
“Å¢Æ¢§¿¡ö ¸¢Ãó¾¢ÌýÁõ ¦ÁöîÝ¨Ä ÒñÌð
¼Æ¢¸¡Ä¢ø Å¢óÐÅ¢É¡ø «ò¨¾ - ÅÆ¢Â¡ö
ÒÃ¢Ô Å¢¾¢ Â¡Ð ÒÃ¢Â¢§É¡ ¦ÂøÄ¡õ
þÃ¢Ô Å¢¾¢ Â¡Ð Á¢ø¨Ä”
Proper use of Mercury as medicine cures the diseases of eyes, syphilis, eight types
of ulcers (Gunmam), throbbing pain (Soolai), chronic ulcer (Perum Pun).
Beneficial properties:
· It purifies blood, it improves blood and sperms
· Kills the micro-organisms and cures the ulcers
· It cures the diseases of internal and external organs of the body
· It improves memory power, eradicates amnesia
· It strengthens the nerve plexuses
· It develops wisdom through concentration of mind
· It prevents senility and increases the life span.
Special properties:
Mercury, unlike other drugs, is useful in the treatment of diseases caused by both
heat and cold.
9GANDHAGAM
English name : Sulphur
Organoleptic Characters
Taste : Bitter and Astringent
Potency : Hot and Cold
Pirivu : Kaarppu ( Pungent)
Actions : Laxative, Tonic, Antiseptic, Diaphoretic, cholagogue
Types : Pirappu, Vaippu, Nellikkai, Vaana
Nellikkai Gandhagam is the one which is often used in medicine preparations.
:
“¦¿øÄ¢ì¸¡öì ¸ó¾¢ìÌ ¿£ûÀ¾¢¦½ý Ìð¼ Áó¾õ
Åø¨Ä ¸Å¢¨ºÌýÁ Å¡Ô¸ñ§½¡ö - ¦À¡øÄ¡
Å¢¼ì¸Ê Åý §Á¸§¿¡ö Å£ÚÍÃõ §À¾¢
¾¢¼ì¸¢ÃÍ ½£¸Àõ§À¡ó §¾÷”
It is useful in the treatment of 18 types of Skin Diseases, Liver Enlargemet,
Abdominal Distention, Eye Diseases, Chronic Venereal Diseases, Chronic Diarrhea,
Gastric Ulcer, Poisonous Bites, Fever due to Vatham, Chronic Dysentery etc.
Special properties :
Sulphur as an internal medicine heals the diseases effectively in a way similar to
that of mother’s care
10
LINGAM
English name : Cinnabar, Virmilion
Chemical name  : Red sulphide of Mercury(Natural).
Organoleptic Characters:
Taste : Not Specific
Potency : Hot
Actions : Alterative
General properties:
“§À¾¢ÍÃï ºó¿¢ ¦ÀÕÅ¢Ã½ ¿£¦Ã¡Î¾
¸¡¾¸Ê ¸¡ºï ¸ÃôÀ¡ýÒñ -§½¡¾
×Õ ºí¸¾Á¡ äÚ¸ðÊ Ôõ§À¡í
ÌÕÅ¢Ä¢í¸ ºí¸Áò¨¾ì ¦¸¡û”
“¬¾¢ Â¢Ã¾×Õì ¸¡¾Ä¡ü º¡¾¢Ä¢í¸
§Á¡¾¢ Ä¢Ã¾Ì½ ÓüÚ¼Ä¢ü-È£ÐÒÃ¢
Ìð¼í ¸¢Ãó¾¢ ¦¸¡ÎïÝ¨Ä Å¡¾Ó¾ü
Öð¼íÌ §¿¡ö¸¨Ç§Â¡ð Îõ”
It is effective in the treatment of Diarrhea, Pyrexia, Delirium, Utricaria, Diuresis,
Tuberculosis, Scabies, Unkown Insect Bites, Shyphilis, Leprosy, Eczema, Skin Diseases,
Throbbing Pain and Vatha Diseases.
Special properties:
It has the properties of curing the diseases caused by the earth element and cures
the diseases caused by the water element.
11
zinc sulphate
: ¦Åû¨Ç Ðò¾õ,Á¼ø Ðò¾õ, ¿¡¸×ôÒ, ¦ÅûÇ£Â ¯ôÒ
: ¦Åñ¨Á, ¿£Ã¢ø ¸¨ÃÔõ
: ¯¼ø ¯ÃÁ¡ì¸¢, ÐÅ÷ôÀ¢,þº¢Å¸üÈ¢, Å¡ó¾¢Ôñ¼¡ì¸¢
ÓüÈ¢Â ÌÈ¢ôÒñ Ó¨ÇÅ¢Ã½õ ¦ºýÉ¢¾¨Éô
ÀüÈ¢¿¢ýÈ Å¡¾õ À¼÷¸ÃôÀ¡ý Íò¾ Å¢Æ¢ì
¸¡ºí ¸½õ À¢øÄõ ¸ñ§½¡ö Ìó¾ò ¦¾¡¨ÄÔõ
Å¡ºÁ¢Ì Ðò¾ò¾¡ø Å¡úòÐ.
1.Ðò¾ò¾¡ø ¯ýÁ¡ó¾õ,¸¡ì¨¸ÅÄ¢,Ý¾¸ ºýÉ¢ ¿£íÌõ.
2.þº¢¨Å §À¡ìÌÅ¾üÌõ, ¯¼ÖìÌ Åý¨Á «Ç¢ôÀ¾üÌõ 65 Á¢¸¢
Å£¾õ ¦¿ö
«øÄÐ ¦Åñ¦½ö ¸ÄóÐ ¦¸¡Îì¸×õ.
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English Name : Red orpiment
Arsenic disulphide is a naturally occurring form of arsenic and is found as realgar,
one of the major arsenic containing mineral. Arsenic disulphide insoluble in water and so
poorly absorbed. It there fore represents a much less acute toxic hazard than soluble
arsenic compounds.
Synonyms: Red arsenic disulphide, Arsenic disulphide, Arsenic sulfide, Red orpiment,
Ruby arsenic, Realgar.
Chemical name and formula:Arsenic disulphide( AS2S4)
Physical properties : Red Brown
“ ¸¡öîºø ¿Îì¸ø «º¸øÄ¢ Ô¨ÃôÒî º¢Äó¾¢
§ÀºÚõ Á§É¡ º¢¨Ä §ÀÍ “
Tradional uses :
In fever it is generally used in combination with mercury, orpiment etc . as in the
following svasakuthara rasa is consisting of realgar, mercury, sulphur, aconite, borax,
black pepper, ginger, and long pepper is recommended in remittent fever with cerebral
complications. Dose is 4 grains in pill form.
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English Name :Rock salt , Sodium chloride impure
¨ºó¾Åõ, º¢óÐ¡Ãõ, ºó¾¢ÃÛôÒ, Á¾¢ÔôÒ,
Á¾¢ìÜ÷¨Á,
Á¢ó¾¡î¦º¡ø
:§ÁüÀì¸õ ¸À¢Ä ¿¢Èõ, ¯ðÀì¸õ ¦Åñ¨Á
:
ÁÄ¸¡¡¢ ¦ºö¨¸
“«ð¼ÌýÁ Áó¾õ «º¢÷ì¸ÃïÝ÷ º£¾À¢ò¾ó
Ðð¼¨ÅÂõ  ¿¡ÊôÒñ §¼¡¼í¸û - ¦¸ð¼ÁÄì
¸ðÎÅ¢¼ Å¢ó¨¾¨Âì ¸¡Á¢Â§¿¡ö Åý¸ÃôÀ¡ý
Å¢ðÎÅ¢¼ Å¢óÐô¨À Å¢û “
It is used in the treatment of 8 types of gunmam, Kaba pitham, poison intake,
mutthodam, constipation, diseases of head, eye, tongue, dental roots, chin, neck and
external genital organs.
USES:
1. It is used to treat many kinds of skin diseases and also to reduce pain
in rheumatic ailments.
2. It is used to reduce pain, inflammation and irritation in case of
insect bites. Having the right level of salt assists the body with many
functions including nerve conduction.
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English Name : Copper
: ¸¡÷ôÒ, ¨¸ôÒ
: ¦ÅôÀ Å£¡¢Âõ
¸¡÷ôÒ
:
“¾¡õÀ¢Ãò¾¡ü §º¡¡¢ À¢ò¾õ ºó¿¢ÂÌ¨Å ¸Àõ
Å£õÀ¡÷ À¢Ä¢¸õ Áó¾õ, ¦Åñ§Á¸õ, §¾õÀÆ¨Ä
Ý¾¸§¿¡ö Òñ ¸¢Ãó¾¢ §¾¡¼ ÍÅ¡ºí ¸¢ÕÁ¢
¾¡Ð¿ð¼õ ¸ñ§¿¡ö §À¡õ º¡üÚ “
¦ºö¨¸ : þº¢Å¸üÈ¢
¾¡Á¢ÃÀüÀò¨¾ ¾¡Á¨Ã ,«øÄ¢, ¦¸¡ðÊ þÅüÈ¢ý âîº¡Ú ²¾¡ÅÐ
´ýÈ¢ø ¾Ã ¸¡ì¨¸ ÅÄ¢ ¾£Õõ.
Uses
1. Copper act as Anti-oxidant and Anti-bacterial
2. Copper is used as Immuno-modulator
3. The two radioactive isotopes of copper are used in health care.
4. Copper-64 is used to study brain function.
5. The Ebers Papyrus (c. 1500 BC) mentions the use of copper for headaches,
"trembling of the limbs".
6. Copper dependent enzyme are required for normal brain development and
function. deficiency can result pathological disorder accompanied by convulsive
seizure or tremor in man and animal. administration of therapeutically effective
amount of an organic compound of copper having anti-convulstant activity.
15
Copper-dependent enzymes are required for normal brain development and
function.
Copper deficiency can result in pathological disorders accompanied by convulsive
seizures or tremors in man and animals. The present invention is directed to a method
for treating convulsions or epilepsy comprising administration of a therapeutically
effective amount of an organic compound of copper having anticonvulsant activity.
Those compounds include copper complexes of carboxylic acids, acylsalicylates,
salicylates, amino acids, imines and known anticonvulsant and antiepileptic drugs.
Method for treating convulsions and epilepsy with organic copper compounds
Anticonvulsant Activities of Copper Complexes
The brain contains more copper than any other organ of the body except the liver.
This fact suggests that copper plays a role in brain functions. With reports of seizures
in animals and humans following copper-deficient diets, it was reasoned that copper
has a role to play in the prevention of seizures. It was subsequently discovered that
organic compounds that are not themselves anti-convulsants exhibit anticonvulsant
activity when complexed with copper. Further, it was found that copper complexes of
all anti-epileptic drugs are more effective and less toxic than their parent drugs.
Synthesis, structural analysis and anticonvulsant activity of a ternary Cu(II)
mononuclear complex containing 1,10-phenanthroline and the leading antiepileptic
drug valproic acid.
Anticonvulsant properties of copper acetazolamide complexes.
Abstract
Two copper acetazolamide complexes were synthesized for evaluation as
anticonvulsant agents. These complexes were found to be more effective as
anticonvulsants than the acetazolamide.
16
English Name : Bile
: À¢òÐ
: ÁÄÁ¢Çì¸¢
:
1. ºýÉ¢ §¿¡ö¸ÙìÌ ÅÆíÌõ ¨ÀÃÅ Á¡ò¾¢¨Ã¸¨Ç «¨Ãì¸
ÀÂýÀÎ¸¢ÈÐ.
2. ¸¡ì¨¸ ÅÄ¢ìÌ À¢îº¢ ±ñ¦½ö¨Â ÅÆíÌõ Ó¨Èô ÀüÈ¢
À¡ÄÅ¡¸¼ò¾¢ø ÜÈôÀðÎûÇÐ.
GOAT BILE
The composition of bile varies substantially with in Cholic acid – commonest acid
found in bile deoxycholic acid , chenocholic acid, hyocholic acid, lithocholic acid.
Alcohols
C27 or c28 occur in the biles amphibian fish. Bile acids and alcohols normally occur
in conjugated forms ,acids conjugating with the amino acids” taurine” or “glycine”.
Carnivore biles contain largely salts of cholic acids .
Name Total lipids Billirubin Cholesterol Fatty acid Total
bileacid
Ox 100-160 - 37 370 7200
Dog - 92-170 80-100 1600-5000 7900-15000
Guinea pig 140 - - - 780
Rabbit - 87-131 10-120 - 1100-2600
Rat - 8-9 12.7 - -
Pig - 32-62 130-180 820-2000 8500-12000
Man - 1000 630 970 5180
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English Name : Febrifuge Plant
Botanical name : Solanum surattense Burm.f
: §¸¡¨ÆÂ¸üÈ¢, º¢Ú¿£÷ô ¦ÀÕì¸¢, «¸ðÎÅ¡Â¸üÈ¢
-
CHUKKU
Botanical name : Zingiber officinale Rosc
Family : Zingiberaceae
Parts used : Dried rhizome
Organoleptic Characters
Taste : Acrid
Potency : Hot
Pirivu : Acrid
Actions : Stimulant, Stomachic, Carminative
“Ý¨ÄÁó¾õ ¦¿ï¦ºÃ¢ôÒ §¾¡¼§Áô ÀõÁÆ¨Ä
ãÄõ þ¨ÃôÀ¢ÕÁø ãìÌ¿£÷ - Å¡Ä¸À
§¾¡¼Á¾¢ º¡Ãó ¦¾¡¼÷Å¡¾ ÌýÁ¿£÷ò
§¾¡¼õ ¬Áõ §À¡ìÌï ÍìÌ”
Chemical Constituents:
Camphene, phellandrene, zingiberine, cineol, borneol, gingerol, gingerin,
resin, Starch. Bisabolene, borneol, camphene, cineol, citral, citronellol, geranial,
limonene,linalool, Phellandrene, zingiberene, zingiberol.
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Volatile oils (bisabolene, borneol, camphene, cineol, citral, citronellol,
geranial, limonene, linalool, phellandrene, zingiberene, zingiberol).
The aromatic principles are bisabolene & zingiberene, the pungent
principles are gingerols & shogaols which are anti-nausea. Gingerols turn into
shogaols when exposed to heat and air.
MILAGU
Botanical name : Piper nigrum.Linn
Family : Piperaceae
Parts used  : Dried unripe fruit
Organoleptic Characters
Taste : Bitter, acrid
Potency : Hot
Pirivu : Acrid
Actions : Carminative, Antiperiodic, Rubefacient, Stimulant
Antidote, Resolvent
“º£¾ÍÃõ À¡ñÎ º¢§ÄòÁí ¸¢Ã¡½¢ÌýÁõ
Å¡¾õ «Õº¢À¢ò¾õ Á¡ãÄõ-µÐºýÉ¢
Â¡ºÁÀŠ Á¡Ãõ «¼Ä§Á¸õ ¸¡ºÁ¢¨Å
¿¡ºí ¸È¢Á¢Ç¸¢É¡ø.
§¸¡Ï¸¢ýÈ Àì¸ÅÄ¢ ÌöÂ×§Ã¡ ¸õÅ¡¾
§º¡½¢¾í¸ Øò¾¢üÌû §¾¡ýÚ§¿¡ö-¸¡½Ã¢Â
¸¡Ð§¿¡ö Á¡¾÷ÌýÁí ¸¡Á¡¨Ä Áó¾¦ÁýÈ£÷
²Ð§¿¡ö ¸¡Â¢Õì¸¢ø ®íÌ.”
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“¾£Â¡¸¢ ¦ÂíÌõ ¾¢Ã¢ÔÁ¨¾ Â¡ÅòÐ
§Á¡Â¡Á ¦ÄôÀÊÔ Óñ¼¡ì¸¡ü-À¡Â¡Ð
§À¡ó¾¢Á¢÷Å¡ ¾í¸¢Ãó¾¢ Òñ½£Õõ Áñ½Å÷ìÌõ
¸¡ó¾¢¦ÁöÅ¡ ¾îºÖô¨Àì ¸¡ö.”
Á¢ÇÌ, ÅÇ¢, ¾£, ¸ÀìÌüÈí¸û «¨Éò¨¾Ôõ ¿£ìÌõ. «ýÈ¢Ôõ
¾¢Á¢÷Å¡¾õ, ¸Æ¨Ä, ÅÇ¢, ºÇ¢ ¬¸¢ÂÅü¨È «¸üÚõ.
Phytochemicals: Piperine, piperidine.
The principle ingredients of Piper nigrum are dimeric amide alkaloids with
cyclohexene ring, nigramides, dimeric amide alkaloids with cyclobutane ring, nigramides
P-S.
Uses:
It is useful in treating cold, cough, fever, gastric ulcer, haemorrhoids, vatha
diseases, etc. It is an effective antidote.
Chemical Constituents:
Chavicine, piperine, piperidine, essential oil, safrol, tannic acid,
piperamide, pyrrolidine, piperolein – b, balsamic volatile oil.
THIPPILI
Botanical name : Piper longum Linn
Family : Piperaceae
Parts used : Dried unripe fruit
Organoleptic Characters
Taste : Acrid
Potency : Hot
Pirivu : Sweet
Actions : Stimulant and Carminative
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“¬ºÉ§¿¡ö ¦¾¡ñ¨¼ §¿¡ö ¬ÅÃ½ À¢ò¾Ó¾ø
¿¡º¢Å¢Æ¢ ¸¡¾¢¨Å§¿¡ö ¿¡ðÒØ§¿¡ö - Å£º¢ÎÅ¢
Âí¸Ä¡ïº Éïº¢¨¾Ôõ «õÀ¡ö «Æ¢Å¢óÐõ
¦À¡í¸Ä¡ïº ¿í¨¸Â÷§¸¡ð §À¡ø”
Chemical Constituents:
Resin, Volatile Oil, Starch, Fatty Oil, Piperine. The fruits contain 1%
volatile oil, resin, a waxy alkaloid, a terpenoid substance and alkaloids piperine
and piperlongumine
VEMBU
English Name  : Neem
Botanical Name  : Azhadirachta indica.A.Juss.
Family   : Meliaceae
Parts used   : Leaf, unripe fruit, ripe fruit, seed
Organoleptic characters:
Taste : Bitter
Potency : Hot
Pirivu : Acrid
Phytochemicals  :Margosine
Activities  :timulant, Anthelmintic, Discutient, Antiseptic, Insecticide
“Å¡¾õ§À¡õ À¢ò¾Á¢Ìõ Á¡È¡ì¸¢ Ãó¾¢¦Â¡Î
§Á¡Ð¸Ãô À¡ýº¢ÃíÌ ÓýÉ¢º¢×õ -´Ð¼Ä¢ý
¿¡ôÀ ÏÚÍÃÓ ¿¡ÎºýÉ¢ Ôó¦¾¡¨ÄÔõ
§ÅôÀ¦¿ö ¦Âý¦È¡Õì¸¡ø Å¢ûÙ”.
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Effects of piperine on convulsions and on brain serotonin and catecholamine
levels in E1 mice.
Convulsions of E1 mice were completely suppressed by 60 mg/kg of piperine
injected intraperitoneally. The ED50 was 21.1 mg/kg. The brain 5-HT, dopamine and
norepinephrine levels were estimated 1 hour after the intraperitoneal injection of piperine.
The 5-HT level was significantly higher in the cerebral cortex of piperine treated mice
than in control mice. This increase may be related directly to the mechanism of inhibition
of convulsions by piperine. On the other hand, lower levels of 5-HT were observed in the
hippocampus, midbrain and cerebellum. The dopamine level in the piperine treated mice
was markedly higher only in the hypothalamus, while the norepinephrine levels were
lower in every part of the brain.
A review of pharmacology and clinical use of piperine and its derivatives
Piperine and its derivatives are effective anticonvulsant drugs that antagonize
convulsions induced by physical and chemical methods. Their major anticonvulsant
activity as shown in animal tests lies in modification of the maximal electroshock seizure
pattern. They also have sedative-hypnotic, tranquilizing, and muscle-relaxing actions and
can intensify the depressive action of other depressants, when used in combination.
Antiepilepsirine, one of the derivatives of piperine, is used as an antiepileptic drug in
treating different types of epilepsy. It has been proved effective and is being widely used
in China. The anticonvulsant action of 7446, 7448, and 7903 is more potent than that of
antiepilepsirine. The chemical structure of piperine and its derivatives is different from
that of prototype antiepileptic drugs, and, therefore, these may become a new group of
antiepileptic drugs.
Anticonvulsant activity of piperine on seizures induced by excitatory amino acid
receptor agonists.
In traditional Chinese medicine, a mixture of radish and pepper is used to treat
epilepsy. The presumptive effectiveness of this prescription might be due to the
anticonvulsant actions of the principal component of pepper, the alkaloid piperine (CAS
94-62-2). The effects of piperine on convulsions induced in mice by agonists at different
excitatory amino acid receptor subtypes were studied. Piperine was shown to significantly
block convulsions induced by intracerebroventricular injection of threshold doses of
kainate, but to have no or only slight effects on convulsions induced by L-glutamate, N-
methyl-D-aspartate or guanidinosuccinate. Piperine suspensions, injected
intraperitoneally, 1 h before injection of the threshold intracerebroventricular dose of
kainate for the induction of clonic convulsions (1 nmol), blocked these convulsions with
an ED50 (and 95% confidence interval) of 46 (25-86) mg/kg. Although piperine did block
convulsions, induced by kainate, the compound does not appear to act as a kainate
receptor antagonist. Whole-cell currents induced by the application of kainate to spinal
cord cells in primary dissociated cultures were not affected by co- application of piperine.
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Diet
The ketogenic diet, which includes high amounts of fat and very low amounts of
carbohydrates, is an age-old treatment for epilepsy that has been revived in recent years.
The diet effectively reduces seizures for some people, especially children, but it is
difficult to maintain.
Researchers are trying to learn exactly how the ketogenic diet prevents seizures.
They hope to find ways to chemically mimic its seizure-blocking effects without the
dietary restrictions.
Several studies have suggested that substances called beta-hydroxybutyrate (BHB)
and acetoacetate, which increase in people who follow the ketogenic diet, play a role in
blocking seizures.
Other researchers used a chemical called 2-deoxy-D-glucose (2DG) to block
carbohydrate breakdown in a rat model of epilepsy. This chemical reduced the expression
of genes involved in epilepsy and reduced the number and severity of seizures in the rats.
If this substance works in people, it might be the basis for a new class of antiepileptic
drugs.
Studies are examining which types of seizures and epilepsy syndromes respond
best to the ketogenic diet. Studies have shown particularly good results with infantile
spasms, pyruvate dehydrogenase deficiency, and glucose transporter protein deficiency.
The diet is also useful for some people with other forms of epilepsy.
Several clinical studies are now testing whether the high-protein Atkins diet and
other diets that are less extreme than the ketogenic diet may help to reduce seizures.
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þØôÒ, þº¢× §¿¡ö
þó§¿¡ö «È¢× ÌýÈ¢ò ¾ý ¿¢¨Ä Á¡ÚÀðÎò ¾ý¨ÉÂÈ¢Â¡Á§Ä
¨¸Ôí ¸¡Öõ ÅÄ¢òÐ þØò¾ø, Å¡Â¢ø Ñ¨Ã ¾ûÇø, Å¡ö §¸¡½¢ì
¦¸¡ûÙ¾ø ,¸ñÀ¡÷¨Å ´ÕÒÈÁ¡¸ þØòÐì ¦¸¡ûÇø ±ýÛõ
þÂøÒ¨¼Â¾¡õ.
:
þó§¿¡Â¡ÉÐ §Á¸ §¿¡öìÌò ¦¾¡¼÷À¡¸ ÅÕõ ±É×õ, ¯¼ø ¿¢¨ÄÔõ
ÁÉ ¿¢¨ÄÔõ ¦¸Î¾Ä¡Öõ ÅÕõ ±É×õ, «¨Å ³Âò¨¾ Á¢Ì¾¢ôÀÎòÐõ
¯½Å¡¾¢¸Ç¡Öõ ¦Àñ½¢î¨ºÂ¢ø Á¢Ì¾¢Ôõ ®ÎÀ¼ø, ¦ÀÕõ «È¢»÷¸¨Çô
ÀÆ¢ò¾Ä¡¸¢Â ¿¼ò¨¾¸Ç¡Öõ ¯ñ¼¡Ì¦ÁÉì ÜÈ¢ÔûÇ¡÷¸û.
´Õ º¡Ã¡÷ þ¾¨É ³Å¨¸ ÅÄ¢ ±É×õ, Áü¦È¡Õ º¡Ã¡÷ þ¾¨É
þÕÀò¦¾¡Õ Å¨¸Â¡¸×õ À¢¡¢òÐûÇ¡÷¸û.
1.ÓôÀ¢½¢ ÅÄ¢ ( ÌÁÃ¸ñ¼ý )
2.Ì¾¢¨Ã ÅÄ¢ ( «ÁÃ¸ñ¼ý )
3.ÌÃíÌ ÅÄ¢ ( À¢ÃÁ ¸ñ¼ý )
4.¸¡ì¨¸ ÅÄ¢
5.ÓÂø ÅÄ¢ ( ÓÂÄ¸ý ) ±ýÀ¨ÅÂ¡õ.
(2) þÕÀò¦¾¡Õ Å¨¸ ÅÄ¢ §¿¡ö¸Ç¡ÅÉ :
1. «ÁÃ¸ñ¼ý ÅÄ¢
2. ÌÁÃ¸ñ¼ý ÅÄ¢
3. À¢ÃÁ¸ñ¼ý ÅÄ¢
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4. ¸¡ì¨¸ ÅÄ¢
5. ÓÂø ÅÄ¢
6. ¾¢Á¢÷ ÅÄ¢
7. §¸¡Û ÅÄ¢
8. ºñ¼¡Ç ÅÄ¢
9. ÁÃ½ ÅÄ¢
10. Á§É¡ ÅÄ¢
11. ¿ïÍ ÅÄ¢
12. ÓìÌüÈ ÅÄ¢
13. ³Â ÅÄ¢
14. Å¢ø ÅÄ¢ ( ¾Û÷ ÅÄ¢ )
15. ÍÃ ÅÄ¢
16. Å¢ì¸ø ÅÄ¢
17. ¾¨Ä ÅÄ¢
18. §¸¡¨Æ ÅÄ¢
19. µÎ ÅÄ¢
20. Á¡÷Ò ÅÄ¢
21. ¾ÁÃ¸ ÅÄ¢ ±ýÀ¨Å¸Ç¡õ.
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1. º¡üÈ¢§É¡õ ¸ñ¸¨ÇÔ ÁÄÃô À¡÷ìÌõ
º¡í¸Á¡ö ÁÄºÄÓï ºÕ¸¢ Å£Øõ
Á¡üÈ¢§É¡ï º¢§ÄðÎÁò¾¢ø À¢Èó¾ §Ã¡¸õ
ÁÂì¸Ó¼ý ¸¡ø¨¸¸û Ó¨ÈòÐì ¦¸¡ûÙõ
ÜüÚÅÉ¡ó ¦¾¡ñ¨¼¾É¢ø §¸¡¨Æ §º÷óÐ
ÌÈ¢ôÀ¡É ¿¡×ÄÃø ÌÇ¡¢ô §ÀÍõ
¸¡üÈ¢É¢Öõ §Å¸Á¾¡ö ´ðÊì ¦¸¡øÖõ
¸¡ÄÉ¡í ¸¡ì¨¸ÅÄ¢ ¾ý¨Á Â¡§Á
2. «È¢Ôí ¸¡ì¨¸ ÅÄ¢¾¡Ûõ
«ÄÕõ ¸ñÏõ §Áø §¿¡ì¸¢
À¢¡¢Ô ÁÄÓï ºÄ¿£Õõ
¦ÀÕ¸¢ì ¸¡üÚ¨¼Ô Á¼ì¸¡Áø
¦ºÈ¢Ôó ¦¾¡ñ¨¼ ¿¡×Ä÷óÐ
º¢§ÄòÁõ Á¢ïº¢ì ºÇ¢§Å÷¨Å
ÌÈ¢Â¡õ Å¡¾ À¢ò¾¨ÁÂí
¦¸¡ñ¼ ºýÉ¢ Â¢Ð¾¡§É
±ýÈ¾¡ø, þó§¿¡Â¢ø «ÄñÎ «ÄñÎ ÀÂôÀÎ¾ø, ¸ñ¸û §Áø§¿¡ì¸¢
ÁÄÃ ÁÄÃ Å¢Æ¢ò¾ø, ¦¾¡¨¼Â¡ÉÐ Á¼ì¸ ÓÊÂ¡Áø Å¢¨ÈòÐì ¦¸¡ûÇø,
¦¾¡ñ¨¼Ôõ ¿¡×õ ¯Ä÷¾ø, ³Âô ¦ÀÕì¸¢É¡ø ¦¾¡ñ¨¼Â¢ø §¸¡¨Æ
¸ðÊì ¦¸¡ñÎ «¾¨Éì ¸ìÌ¾ø, º¢Ú¿£Õõ ÁÄÓõ «¾¢¸Á¡¸ô §À¡¾ø,
Å¢Â÷¨Å Ôñ¼¡¾ø Ó¾Ä¢Â ÌÈ¢ Ì½í¸¨Çô ¦ÀÚõ. þó§¿¡ö ³Âì
ÌüÈò¾¡ø À¢ÈìÌ¦ÁÉ¢Ûõ ºýÉ¢À¡¾ì ÌÈ¢ Ì½í¸¨Ç ¯ñ¼¡ìÌõ. §¿¡ö
ÅÕõ§À¡Ð Ó¸ò¨¾ì ¸£ú§¿¡ì¸¢ ¨ÅòÐô ÀÎôÀÃ¡õ.
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ÅÄ¢ §¿¡ö ¦ÀÕõÀ¡ý¨ÁÔõ º¢Ú ÅÂ¾¢ø ÅÕÅ¾¡Ìõ. ¿ÎÅÂÐ
Å¨ÃìÌõ º¢ÄÕìÌ ¿£ÊôÀÐñÎ. ¿¡üÀÐ ÅÂÐ Å¨ÃìÌõ ¿¢¨ÄôÀÐÓñÎ.
¨¸ìÌÆó¨¾¸ÙìÌ ÅÕõ ÅÄ¢ ÀýÉ¢ÃñÎ «øÄÐ À¾¢¨ÉóÐ ÅÂÐ
Å¨ÃÂ¢Öõ Å¢ðÎ Å¢ðÎ ÅÕÅÐÓñÎ.
º¢ÄÕìÌô §Àº¢ì ¦¸¡ñÊÕìÌõ§À¡§¾¡ ²§¾Ûõ §Å¨Ä ¦ºöÐ
¦¸¡ñÊÕìÌõ§À¡§¾¡ ¾¢Ë¦ÃÉ ÅÄ¢§¿¡ö ÅÕÅÐñÎ. º¢ÄÕìÌ ÅÄ¢
ÅÕÅ¾üÌ Óý§À ÅÄ¢ ÅÃô§À¡¸¢ýÈÐ ±ýÛõ ¯½÷îº¢¨Â ¯ñ¼¡ì¸¢,
Á¢Ìó¾ º¢Éõ, ÁÂì¸õ, ÁÉî§º¡÷×, §º¡õÀø, Á¢Ìó¾ Àº¢, ¦ÅÕñ¼ À¡÷¨Å
¬¸¢Â ÌÈ¢Ì½í¸¨Çì ¸¡ðÊ þØôÒ ¦¾¡¼Õõ.
«ýÈ¢Ôõ «Êì¸Ê ÐõÓ¾ø, ¦¸¡ð¼¡Å¢ Å¢¼ø, ¯¼Ä¢ý º¨¾
ÐÊò¾ø, ÁÂì¸õ, ¯½÷îº¢ÂüÚì ¸¢¼ò¾ø, º¢Ú¿£÷ ¸Æ¢Â¡¾¢Õò¾ø, Å¡Â¢ø
Ñ¨Ã ¾ûÇÄ¡¸¢Â ÌÈ¢Ì½í¸¨ÇÔõ ¦ÀÚõ. º¢Ä ¿¡Æ¢¨¸ ¦ºýÈÀ¢ý ¦¾Ç¢óÐ
±Øó¾¢ÕôÀ÷. º¢Ä ºÁÂõ þùÅÄ¢Â¡ÉÐ ±Ç¢¾¢ø Å¢ðÎ Å¢ÊÛõ ´Õ
¿¡¨ÇìÌô ÀýÓ¨È ÅÕÅÐñÎ «øÄÐ ¿¡û ¸½ì¸¢ýÈ¢ ¿¢¨Éò¾
§À¡¦¾øÄ¡õ ÅÄ¢ ÅÕÅÐñÎ. ´Õ ¿¡¨ÇìÌô ÀýÓ¨È «Îò¾ÎòÐ ÅÄ¢
ÅóÐ ¦¸¡ñÊÕôÀ¢ý §¿¡ö ÓüÚõ ¦¾Ç¢óÐ ¿¢¨É× ¯ñ¼¡Å¾üÌî ºüÚ
¾¡Á¾Á¡Ìõ.
ÁüÚõ º¢Ä þØôÒ¸Ç¢ø ¨¸ ¸¡ø¸Ç¢ý Å¢Ãø¸û ¦¸¡ÚìÌ ÅÄ¢ §À¡ø
Á¼í¸¢ò ÐÊôÒñ¼¡Ìõ. ¾¨ÄÔí¸ñÏõ ´Õ ÒÈò§¾ þØìÌõ. «È¢×
Ì¨ÈóÐ ÁÂì¸Óñ¼¡Ìõ. ¨¸Ôí¸¡Öõ Á¼ì¸ ÓÊÂ¡Áø Å¢¨ÈòÐ ¯¾Úõ.
¸ñ Å¢Æ¢òÐì ¦¸¡ñ§¼Â¢Õì¸î ¦ºöÔõ. ¯½÷îº¢¨Âì ¦¸ÎòÐ, ¯¼¨Äô
À¢ýÛõ ÓýÛõ Å¨ÇòÐ þØòÐì ÜìÌÃÄ¢Îõ. Å¡ö §¸¡½Ä¡Ìõ.
Àü¸ÊìÌõ. ¿¡¨Åì ¸ÊòÐì ¦¸¡ûÙõ, ãîÍò ¾¢½Úõ, ¦¾¡ñ¨¼ ¸ðÎõ,
¯¼ø ¸ÚòÐô§À¡õ. Å¡Â¢ø Ñ¨ÃÔõ ÌÕ¾¢Ôõ ¸ÄóÐ ¦ÅÇ¢Â¡Ìõ.
ãì¸¢Ä¢ÕóÐõ ÌÕ¾¢ ¸º¢ÅÐÓñÎ. þùÅ¡Ú ¦¸¡Î¨Á¸û ÀÄ ¦ºöÐ, º¢Ä
¿¡Æ¢¨¸ìÌû ÅÄ¢ Ì¨ÈóÐ ¦¸¡ñ§¼ ÅóÐ, À¢ÈÌ ¯½÷îº¢ ¦ÀüÚ
±Øó¾¢Õì¸î ¦ºöÔõ. ÅÄ¢ Å¢ðÎ ±Øó¾ §À¡¾¢Öõ ¾¡í¸ ÓÊÂ¡¾ ¾¨Ä
ÅÄ¢Ôõ §º¡÷×õ Ð¡ì¸Óõ ±Øõ.
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º¢Ä÷ ÅÄ¢ Åó¾§À¡Ð Ó¸ò¨¾ì ¸£úÒÈÁ¡¸, ¾¨Ã§ÁÄ¡¸¢Öõ, ÀÎì¨¸
§ÁÄ¡¸¢Öõ ¨ÅòÐì ¦¸¡ûÅ÷. þ¨¾ì ¸¡ì¨¸ ÅÄ¢¦ÂÉì ÜÚÅ÷. þùÅÄ¢
þÃÅ¢ø Ð¡íÌõ§À¡Ð Å¡¢ý º¢Ä §Å¨Ç ÁÃ½ò¨¾Ôõ ¯ñ¼¡ìÌõ ±ýÀ÷.
ÁüÚõ º¢ÄÕìÌ þùÅÄ¢Â¢ø º¢Ú¿£÷ ¾ý¨ÉÂÈ¢Â¡Á§Ä þÆ¢ÅÐÓñÎ.
ÅÄ¢ì ¦¸¡Î¨ÁÂ¡ø º¢Ä ºÁÂõ ¯¼õÀ¢ø «ÊÀðÎ Å£íÌ¾ø, ¸¡ÂÓñ¼¡¾ø,
±ÖõÒ¸û ÓÈ¢¾ø, ¯¼ø ÓØ¨ÁÔõ §¿¡¾ø, ÌÕ¾¢ Å¡ó¾¢Â¡¾ø Ó¾Ä¢Â
ÌÈ¢Ì½í¸¨ÇÔõ Å¢¨ÇÅ¢ì¸ìÜÎõ. §¿¡Â¢ý ¦¸¡Î¨Áì§¸üÀ þó§¿¡Ô¼ý
Àì¸Å¡¾Óõ (À¡¡¢ºÅ¡Ô, Àì¸Å¡Ô) ¦¾¡¼ÕÅÐñÎ.
ÌÆó¨¾¸ÙìÌ ÅÕõ §¿¡Â¢ø, §¿¡ö ÅÕÅ¾üÌ Óý§À ÍÃí¸¡öóÐ
Å¢Ãø¸û ÐÊôÀÐõ, ¨¸ ¸¡ø¸Ç¢ý º¨¾¸û ÐÊôÀÐÁ¡¸Â¢ÕóÐ «ôÀ¡ø
ÌÆó¨¾ ¾¡í¸ ÓÊÂ¡¾ þØô¨À ÅÕÅ¢ìÌõ. ¦ÀÕõÀ¡Öõ ÌÆó¨¾¸Ç¢ø
ÁÄîº¢ì¸Ö¼ý º£¾Óñ¼¡öî ÍÃõ ¬ÃõÀ¢ìÌõ ÓýÉ¾¡¸§Å ¦À¡¢ÂÅ÷¸ÙìÌ
ÍÃõ ÅÕÓý ÌÇ¢Õõ ¿Îì¸ÖÓñ¼¡ÅÐ §À¡Ä, ÌÆó¨¾¸Ç¢ø §ÁüÜÈ¢Â
þº¢× ±ýÛõ þØôÒ ¯ñ¼¡Ì¦ÁýÀ¨¾ ¿¢¨É×ÀÎò¾¢ì ¦¸¡ûÇ×õ. ÍÃõ
«¾¢¸ôÀÎõ§À¡Ð þº¢×õ «Êì¸Ê ¯ñ¼¡¸¢ ºýÉ¢¨ÂÔõ À¢ÈôÀ¢ì¸ìÜÎõ.
þùÅ¢º¢× ÌÆó¨¾¸Ç¢ø ´Õ ¿¡¨ÇìÌô ÀÄ Ó¨È¸û ÅÕÅÐñÎ. ÅÄ¢
ÅÕõ§À¡¦¾øÄ¡õ ¸ñ¸û §Áø §¿¡ì¸¢ þØòÐì ¦¸¡ûÙõ. Å¡ö §¸¡½¢ ´Õ
ÒÈÁ¡¸ ÅÄ¢òÐì ¦¸¡ûÙõ. ¾¨Ä ´Õ Àì¸Á¡¸ò ¾¢ÕõÀ¢Â¢Õò¾ø, ¿¡×õ ´Õ
ÒÈÁ¡¸ þØòÐì ¦¸¡ûÇø ±ýÛõ ÌÈ¢ Ì½í¸¨ÇÔõ ¸¡ðÎõ.
ÌÆó¨¾¸ÙìÌñ¼¡Ìõ ÅÄ¢ §¿¡Ô¼ý º¢Ä ºÁÂõ “Àì¸ Å¡¾Óõ”
À¢ÈôÀÐñÎ. º¢Ä ÌÆó¨¾¸Ç¢ø ¸ñ À¡÷¨Å Ì¨ÈÅÐõ, ¸ñ ¦º¾¢÷ÅÐõ
( «¾¡ÅÐ ´Ç¢ ÁØíÌ¾ø ²üÀÎõ ) ¯ñÎ.
¦À¡ÐÅ¡¸ ÅÄ¢ §¿¡ö ÁÕòÐÅò¾¢ü ¸¼í¸¡Ð ¿£Êò¾¢ÕôÀ¢ý º¢Ä
§Å¨Ç ¦¸¡ïºí ¦¸¡ïºÁ¡¸ «È¢¨Åì ¦¸ÎòÐ ¦ÅÈ¢ §¿¡¨Â
ÅÕÅ¢ôÀÐÓñÎ.
º¢Ú ÅÂ¾¢ø ¦¾¡¼íÌõ ÅÄ¢ §¿¡ö¸û º¢Ä Á¡¾í¸û Å¨ÃìÌÁ¢ÕóÐ
ÁÕóÐ¸Ç¡ø Ì½Á¡¸¢ «ôÀ¡ø ¿ÎÅÂ¾¢ø Á£ñÎõ ÅÄ¢ §¿¡ö ÅÕÅÐñÎ.
º¢Ú ÅÂ¾¢ø ÅÄ¢ §¿¡ö §¾¡ýÈ¡Ð ¿ÎÅÂ¾¢ø §¾¡ýÚÅÐÓñÎ.
¦Àñ¸ÙìÌ ÅÄ¢ §¿¡ö ¦ÀÕõÀ¡ý¨ÁÔõ Å£ðÎ Å¢Äì¸õ ²üÀÎõ §À¡Ð
ÅÕõ. «ýÈ¢Ôõ ¸÷ôÀ¢½¢¸ÙìÌõ ÅÄ¢ §¿¡ö ¯¼ø ¿¢¨Ä º¡¢Â¢øÄ¡¾
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¸¡Ã½ò¾¡ø ²üÀÎÅÐñÎ. ¸÷ôÀÁ¡ÔûÇ §À¡Ðõ «øÄÐ À¢ÃºÅ
§Å¾¨ÉôÀÎõ§À¡Ðõ «øÄÐ À¢ÃºÅ¢ò¾ À¢ýÛõ («¨È Å£ðÊø) ÅÄ¢ §¿¡ö
¦¾¡¼ÕÅÐñÎ.
ÌÆó¨¾¸ÙìÌ ÅÕõ º¢ÄÅ¨¸ ÅÄ¢ §¿¡Â¢ø «È¢× ÌýÈ¡Á§Ä
¨¸¸¡ø¸¨Çò Ð¡ì¸¢ò Ð¡ì¸¢ô §À¡Î¾ø, ÍÃõ, Á¡÷À¢ø §¸¡¨Æ ¸ð¼ø, Å¡ö
§¸¡Ï¾ø Ó¾Ä¢Â ÌÈ¢Ì½í¸û ²üÀðÎ º¢È¢Ð §¿Ãò¾¢ø «ùÅÄ¢
¿¢ýÚÅ¢ÎÅÐÓñÎ. ´Õ ¿¡¨ÇìÌ ¿¡¨ÄóÐ Ó¨È ÅÄ¢ò¾ÖÓñÎ. þ·Ð
±Ç¢¾¢ø ¾£Ã¡¦¾É×õ, ¾ì¸ ÁÕòÐÅò¾¢ø ¾£Õ¦ÁÉ×õ ÀÄÅ¡É «À¢ôÀ¢Ã¡Âõ
ÜÚÅ¡÷¸û. þ¾¨Éò “ ¦¾ü¸ò¾¢ì ¸¨½ “ ±ýÚõ, ¾£ÕÅÐ «¡¢Ð ±É×õ
ÜÚÅ÷. Ì¼ü¸¢ÕÁ¢ÔûÇ ÌÆó¨¾¸ÙìÌ ÅÄ¢ §¿¡ö ÅÕÅÐñÎ.
MODERN ASPECT
EPILEPSY
Definition :
A seizure is any clinical event caused by an abnormal electrical discharge in the brain,
epilepsy is the tendency to have recurrent seizure. Epilepsy should be regarded as a
symptom of brain disease rather than a disease itself. A single seizure is not epilepsy but
an indication for investigation , and medication should generally be withheld until
recurrent seizures occur.
WHO Defines Epilepsy as “a disorder of the brain characterized by an endurg
predisposition to generate Epileptic seizures, and by the neurological, cognitive,
psychological and social consequences of this condition”. A Transient occurrence of
signs or symptoms due to abnormal excessive or synchronous neuronal activity in the
brain.
 Epilepsy is common in children with IQ less than 50.
 Many of the inherited,idiopathic epilepsies – due to mutations affecting ion
channel functions.
 Whereas mutations observed in symptomatic epilepsies – neuronal homeogenesis
or CNS
development.
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 1 in 200 of general population have epilepsy.
 The brain is built up of many billions of nerve cells, the neurons.
 The function of the neurons is to send out electrical impulses which pass from
neuron to neuron with the help of chemical "messengers", the neurotransmitters.
 When the electrical impulse reaches the end of a neuron, a chemical substance is
released which sets off a reaction in the "receiver area", a so-called synapsis in
the next nerve cell. This enables the electrical impulse to travel on through this
cell to the next
In this way electrical impulses are transmitted along the innumerable neuron chains
which are found in the brain
CAUSES OF EPILEPSY
Neonates (< 1 month )
 Perinatal hypoxia and ischemia
 Intracranial hemorrhage and trauma
 Acute CNS infection
 Metabolic disturbances (hypoglycemia,hypokalemia,hypomagnesemia,pyrodoxin
deficiency)
Infants and children (>1 month and <12 years)
 Febrile seizures
 Genetic disorders(metabolic,degenarative,
primary epilepsy syndromes)
 Developmental disorders, trauma.
 Idiopathic
Adolescents (12-18 years)
 Illicit drug use
 Trauma
 Genetic disorders
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 Brain tumor
 Infections
 Idiopathic
Young adults (18-35 years)
 Trauma
 Alcohol withdrawal
 Illicit drug use
 Idiopathi
 Brain tumour
Older adults (>35 years)
 Cerebro vascular diseases
 Brain tumor
 Alcohol withdrawal
 Metabolic disorders (uremia,
hepatic failure,
electrolyte abnormalities,
hypoglycemia)
Alzheimer’s disease
31
CLASSIFICATION OF EPILEPSY
INTERNATIONAL CLASSIFICATION OF EPILEPTIC SEIZURES:
I. Partial seizures
A. Simple partial seizures
I. With motor signs
(a). Focal motor without march
(b). Focal motor with march (Jacksonian)
(c). Versive
(d). Postural
(e). Phonatory
II. With somato sensory or special-sensory symptoms
(a.) Somato sensory
(b) Visual
(c) Auditory
(d) Olfactory
(e) Gustatory
(f) Vertiginous
III. With autonomic symptoms or signs
IV. With psychic symptoms
Dysphasia
Cognitive
Affective
Illusions
B. Complex partial seizures
1. Simple partial seizures at onset, followed by impairment of consciousness
2. With simple partial features
3. With automatisms
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C. WITH IMPAIRMENT OF CONSCIOUSNESS AT ONSET
(a) With impairment of consciousness only
(b) With automatisms
C. PARTIAL SEIZURES EVOLVING TO SECONDARILY GENERALIZED
SEIZURES
1. Simple partial seizures evolving to generalized seizures
2. Complex partial seizures evolving to generalized seizures
3. Simple partial seizures evolving to complex partial seizures evolving to
generalized
seizures
II. Generalized seizures
A. Absence seizures
1. Typical absence seizures
(a) Impairment of consciousness only
(b) With mild clonic components
(c) With atonic components
(d) With tonic components
(e) With automatisms
(f) With autonomic components
2. Atypical absence seizures
B. Myoclonic seizures
C. Clonic seizures
D. Tonic seizures
E. Tonic-clonic seizures
F. Atonic seizures
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PARTIAL EPILEPSY
 Partial seizures or focal seizures are due to a small epileptic focus in the brain.
 They are of 2 types:
1.Simple partial – Seizure start as a focal discharge and remains focal
throughout (without altered consciousness)
2.Complex partial – seizures start as a focal discharge (altered consciousness)
SIMPLE PARTIAL SEIZURES
 Have motor,sensory,autonomic or psychic manifestations.
 Simple partial motor seizures – discharging epileptic focus in the opposite frontal
lobe (motor cortex).
Jacksonian epilepsy – clonic contractions start in fingers of one hand, one side of the
face or the foot and slowly spread to the other muscles on the same side of the body
COMPLEX PARTIAL SEIZURES
 In this seizures consciousness is lost or impaired.
 They are frequently due to epileptic discharges in the temporal or frontal lobes.
 This forms the single most common type of seizures in adults.
 Temporal lobe origin – auditory or visual hallucination, sometimes olfactory or
gustatory hallucinations may be present.
GENERALIZED SEIZURES
 TONIC CLONIC SEIZURE:
Also called as grand mal epilepsy.
4 Stages of Grandmal Epilepsy
1.prodromal phase
2.Tonic phase
3.clonic phase
4.postictal phase
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PRODROMAL PHASE:
Starts several hours before fits.
It consists of subjective phenomenon like depressed or apathetic mood,
irritability, vague abdominal cramps which is easily recognized by the patients.
Sometimes the patient gets the attack without any forewarning.
TONIC PHASE:(10-30 seconds)
It consists of rolling up of the eyes associated with stiffening of the limbs
Clenching of the jaws
Often resulting in injury to the tongue.
Epileptic cry – since entire musculature goes in to spasm forcing air through the
closed vocal cord
CLONIC PHASE: (1-2 minutes)
It is characterized by alternate flexion-extension movements of all the four limbs
convulsions).
Strenuous breathing, sweating
Frothing of the mouth and excessive salivation.
Urine and feces may be voided.
Followed by comatose state(5 minutes)
POST ICTAL STATE:
In this state the patient does not remember anything that had happened.
Pupils begin to react and the patient then resumes speech, but still remains
confused.
Patient starts sleeping for several hours, often wakes up with severe headache and
at times vomiting
ABSENCE SEIZURES
 Known as petit mal seizures
 Seen mostly in children
 It is distinguished by brevity and absence of motor phenomenon.
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 Vacant stare – child abruptly stops all ongoing motor activity and speech. External
stimuli fail to evoke any response from the patient.(2-10seconds).
ATONIC SEIZURES
 Less common generalized seizures characterized by sudden loss of postural tone
and consciousness without any other motor phenomena.
This has to be distinguished from cataplexy
PATHO PHYSIOLOGY
 Pathology consists of:
1.Cell death
2.Axonal sprouting
3.Reorganisation of neural networks
4.Alteration in the release of neuro transmitters.
EPILEPSY IN CEREBRAL HEMORRHAGE OR STROKE
 CAUSE:
Hemorrhage and stroke in brain - cause destruction of brain tissue - formation
of scars -irritate the surrounding nerve tissue.
 FREQUENCY:
Starts late in life.
10-15% persons with cerebral hemorrhage and stroke later develops epilepsy.
 SEIZURE TYPE:
Simple partial and secondary generalized type are common.
EPILEPSY AND HEAD TRAUMA
 CAUSE:
During trauma - brain may lack oxygen due to pinching of blood vessels -
seriously irritate the nerve cells - epilepsy.
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 FREQUENCY:
10-15% of persons with head trauma
Risk depends on age and force of blow.
 SEIZURE TYPE:
  Temporal lobe-complex partial seizure
Few cases-status epilepticus.
EPILEPSY AND BRAIN TUMOR
 CAUSE:
Triggered by irritation from a tumor
 FREQUENCY:
Beginning late in life-suspicion of tumor.
Begins after age of 25.
 SEIZURE TYPE:
Simple partial seizure-more common.
Complex partial seizure.
EPILEPSY AND INFLAMMATION OF THE BRAIN
 CAUSE:
Infections-acute phase
Bacterial meningitis-encephalitis-brain abscess. Healed brain TB often causes
epilepsy due to built up of tumor like tissue which later calcifies.
Parasites can cause fluid filled cysts in brain (cysticercosis)-exert pressure on
surrounding brain tissues.
 FREQUENCY:
4% - Bacterial meningitis
Depends on age – Viral meningitis
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 SEIZURE TYPE:
Simple partial seizures.
Generalized convulsions.
EPILEPSY AND MENTAL RETARDATION
 CAUSE:
Congenital brain damage
Hereditary brain disease
Metabolic abnormalities
Chromosome fault
 FREQUENCY:
20-30% of all mentally retarded people suffer by epilepsy.
EPILEPSY AND MULTIPLE SCLEROSIS
 CAUSE:
 Might be caused by viral infection which could have occurred many years before.
 FREQUENCY:
5 – 10 %
 SEIZURE TYPE:
Partial seizures.
EPILEPSY AND ALCOHOL
 CAUSE:
“Kindling”- Give a person alcohol then stop – he develops withdrawal symptoms
– Give them alcohol again – Repeat it many times – their seizure threshold gradually
decrease – so they starts developing seizure even without alcohol withdrawal.
 SEIZURE TYPE:
Abstinense convulsions.
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DIAGNOSIS
1.EEG
2.MRI Scan
3.PET Scan (Positron Emission Tomography )
4.SPECT ( Single Photon Emission Tomography )
5.Neuro Imaging- provides views of brain areas involved in seizure activity.
6.Electrolyte disturbances.
EPILEPSY AND GABA
 Seizure occur when the message delivering system becomes unbalanced.
 GABA-neurotransmitter trigers signals.
 When there is not enough GABA,a person has seizure because the receiving
neurons is flooded with signals.
EPILEPSY AND SERUM PROLACTIN
 “ Serum prolactin level increases 10-20 minutes after suspected event, it should
considered a useful adjunct to differentiate general tonic clonic seizure or complex
partial seizure from psychogenic seizure among adult and older children.”
- American academy of neurology.
WBC COUNT IN EPILEPSY
 Peripheral White Blood cell Count increases after generalized seizure and is
probably transient in nature.
- pub med
SEIZURES WHICH ARE NOT EPILEPSY
1.Single seizures (stress convulsions)
2.Low blood sugar
3.Fainting.
4.Heart disease
4.Reduced blood supply to brain.
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5.Migraine
6.Kinking of blood vessels
7.Narcolepsy
8.Abstinence seizures.
PROGNOSIS
 Over 60% of patients attain remission,which is defined as freedom from seizures
for 2-5 years after stopping their anti epileptic treatment.
 30%- self limiting or remit after short course of treatment.
 30%- easily controlled with drugs
 20%- chronic epilepsy which responds partially to drugs…
MANAGEMENT OF EPILEPSY
 PRIMARY MEASURES:
1.Treatment of acute convulsions.
2.Prophylactic management
 SECONDARY MEASURES:
1.Removal of precipitating factors.
2.Anti epileptic medications.
3.Social rehabilitations.
FIRST AID FOR AN EPILEPSY PATIENT
 The patient is put on soft bed to avoid injuries.
 Tight clothing is loosened and the airway is protected.
 Foreign bodies in the mouth should be removed and a suitable mouth gag is
applied in the position of molar teeth.
 The patient should be kept with head low, to avoid aspiration.
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MATERIALS AND METHODS
Trial drug 1:( Rajarajeswaram)
Collection of raw drugs:
The raw drugs(Rasam, Thutham,Lingam,Gandagam,Manosilai and Nabi) were
brought from the raw drug market and pichu(goat and he-buffalo)Collected from
slaughter house. All above drugs were identified and authenticated by Head of the
Gunapadam Department, National Institute of Siddha, chennai-47.
1. METHOD OF PURIFICATION AND PREPARTION
Rajarajeswaram :( Internal)
Ingredients:
Rasam -105 Gms
Thutham -105 Gms
Lingam -105 Gms
Gandagam -105 Gms
Manosilai - 105 Gms
Nabi -105 Gms
Vepam eerku kudineer - 850Ml
Pichu(goat and he-buffalo) - 260 Ml
Purification process:
Rasam(Mercury):
Rasam -105 gms,Brick powder-require quantity , turmeric powder-require
quantity kuppaimeni juice-3.9 litre.Mercury is triturated with brick powder and turmeric
powder for one hour respectively and washed with water. Then the mercury was boiled
with the juice of kuppaimeni until it was detoxified.
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Paal thutham(Zinc sulphate)
The paal thutham was placed in cow’s urine and heated. It was then washed with
water and dried in sunshade to get purified.
Lingam(Red sulphide of mercury);
Lime juice, cows milk and the kuppaimeni juice are mixed in equal proportion and
allowed to fuse lingam so as to get it in a consolidated potency state.
Gandagam(Sulphur)
The kalkam of maruthani was mixed in cows curd and placed in a mud pot the
mouth of the pot was covered with a cloth. Sulphur was placed over this cloth. The pot
was covered with another pot and buried in the ground. The outer pot was subjected to
puda with five dung cake. The sulphur which melted and settled down is collected. This
procedure was reprated for seven times.
Manosilai(Red orpiment)
Manosilai was is triturated withginger juice for 3 hours. It was then dried to get
purified form.
Naabi(Aconitum ferox);
The Naabi was placed in cow’s urine and put in sun light for seven days. It was
then washed with water and dried to get purified.
Preparation of the medicine:
The equal amount of purified Rasam, purified Paal thutham, purified Lingam,
purified Gandagam, and purified Manosilai were grounded by stone motor and pestle into
fine powder and put together ,then grounded by stone motor and pestle until well mixed
and then added vepam eerku kudineer mixed it and grinded and make villai and dry it.
After drying then put in to mud agal and covered with mud agal then covered the edges
by seelaiman. Then heated by 50 dried dungcake. After cool it mix with purified Nabi
and pichu(goat and he-buffalo) and grinded two days each. Then make a kuligai the size
of kundri((100-110mg).
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LABELLING:
Name of the preparation : Rajarajeswaram
Quantity of the drug : 205gram
Colour : Black
Date of manufacture : 24.06.2012
Dose : 100-110mg
Adjuvant/ vehicle : Thirikadugu kudineer
Indication : Valippu
Date of expiry : 23.06.2013
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STANDARD OPERATING PROCEDURE
Trial drug 2:( Madhana biravam)
Collection of raw drugs:
The raw drugs(Rasam,Gandagam,copper,Manosilai and Indhuppu) were brought from
the raw drug market and pichu(cow bile)Collected from slaughter house. All above
drugs were identified and authenticated by Head of the Gunapadam Department,
National Institute of Siddha, chennai-47
METHOD OF PURIFICATION AND PREPARTION
Madhana biravam:( Internal)
Ingredients:
Rasam -105 Gms
Gandagam -105Gms
Manosilai - 105 Gms
Induppu - 105 gms
Tamira parpam -105 Gms
Siru vazhuthunai juice - 600 Ml
Pichu(cow) - 260Ml
Purification process:
Rasam(Mercury):
Rasam -105 gms,Brick powder-require quantity , turmeric powder-require
quantity kuppaimeni juice-3.9 litre. Mercury was triturated with brick powder and
turmeric powder for one hour respectively and washed with water. Then the mercury was
boiled with the juice of kuppaimeni until it was detoxified
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Gandagam (Sulphur)
The kalkam of maruthani was mixed in cows curd and placed in a mud pot. The
mouth of the pot was covered with a cloth. Sulphur was placed over this cloth. The pot
was covered with another pot and buried in the ground. The outer pot was subjected to
puda with five dung cake. The sulphur which melts and settles down was collected. This
procedure was repeated for seven times.
Manosilai(Red orpiment)
Manosilai was triturated with ginger juice for 3 hours. It was then dried to get purified
form.
Indhuppu (Rock salt);
The Rock salt was kept soaked in vinegar (old rice fomented water) for three days
and isolated to get purified and detoxified form.
Thamira Parpam (Yakoopu Vaithya chindamani 700) :
Raw copper plate was made in to a thin blade by heating and beating then dipping
in the juice of Nochi leaves(Vitex negundo) previously mixed with camphor. The process
was repeated with pirandai (Cissus quadrangular) juice and butter milk. Purified
Ganthagam (purified sulphur) weighing one-fourth by weight of copper blade mixed
added and ground vigorously in kalvam then vallarai (Centella asiatica) juice was added
and ground continuously. Then the semisolid dough like material was made in to villai.
After the drying of villais, they were placed in mud pot and then sealed with mud cloth
and fired in a pudam with 500 cowdung cakes. Then the villais were ground in kalvam.
Fine ash coloured powder without shining was attained. This was stored in a glass
container for usage.
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Preparation of the medicine:
The equal amount of purified Rasam, purified Gandagam, purified Manosilai,
purified Indhuppu, and tamira parpam were grounded by stone motor and pestle into fine
powder and put together ,then grounded by stone motor and pestle until well mixed and
then added siru vazhuthunai juice mix it and grinded and make villai and dry it. After
drying then put in to mud agal and cover with mud agal then cover the edges by
seelaiman. Then heated by 100 dried dungcake. After cool it mix with pichu(cow) and
grinded. Then make a kuligai in the size of jute seed
Labelling:
Name of the preparation : Madhana Biravam
Quantity of the drug : 220 grams
Colour : Pale brown
Dose : 50-55 mg
Adjuvant/ vehicle : Thirikadugu kudineer
Indication : Valippu
Date of manufacture : 16.06.2012
Date of expiry : 15.06.2013
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EVALUATION OF TABLETS
The formulated tablets were evaluated for the following physicochemical characteristics
General appearance
The formulated tablets were assessed for its general appearance and observations
were made for shape, color, texture and odor.
Uniformity of weight
20 tablets were selected and were weighed collectively and individually. From the
collective weight, average weight was calculated. Each tablet weight was then compared
with average weight to ascertain whether it was within permissible limits or not. Not
more than two of the individual weights deviated from the average weight by more than
7.5% for tablets and none by more than double that percentage.
Disintegration Time*
Results:
S.NO
Name of the
tablets
Colour
Uniformity of
weight
Disintegration
Time
1 Rajarajeswaram Black 110 mg No disintegrate
2 Madhana biravam Pale brown 55 mg 7 minutes 10 sec
*sargam laboratory pvt ltd, Guindy,Chennai.
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CHEMICAL ANALYSIS
Preparation of extract:
5 gram of Rajarajeswaram and Madhana biravam tablets are weighed separately
and placed in separate 250 ml clean beakers and added with 50 ml of distilled water. Then
they are boiled well for about 10 minutes seperately. Then they are is cooled and filtered
in a 100 ml volumetric flasks and made up to 100 ml with distilled water respectively.
S.
no
Experiment Observation Inference Rajarajeswaram
Madhana
Biravam
1.
Test for Sulphate
a.2 ml of the above
prepared extract is taken in
a test tube and 2 ml of 4 %
ammonium oxalate solution
is added
b.2 ml of sodium carbonate
extract is added with 2 ml
of dilute hydrochloric acid
until the effervescence
ceases off. Then 2 ml of
Barium Chloride solution is
added
Cloudy
appearance/ white
precipitate is
obtained
A white
precipitate
insoluble in
concentrated
Hydrochloric acid
is obtained
Presence
of sulphate
Presence
of sulphate
is
confirmed
Present
Present
Present
Present
2.
Test for chloride
2 ml of Sodium Carbonate
extract is added with diluted
Nitric acid until the
effervescence ceases. Then
2 ml of silver nitrate
solution is added.
Cloudy white
precipitate
completely
soluble in excess
of Ammonium
hydroxide
solution is
obtained
Presence
of chloride
is
confirmed
Present Present
3.
Test for Phosphate
2 ml of the extract is treated
with 2 ml of Ammonium
molyhdate solution and 2
ml of concentrated Nitric
acid
Presence of
yellow precipitate
/ cloudy
appearance with
yellow color is
obtained
Presence
of
Phosphate
Absent Absent
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4.
Test for Carbonate
2 ml of the extract is treated
with 2 ml of Magnesium
Sulphate solution
Cloudy
appearance /
white precipitate
is obtained
Presence
of
Carbonate
is
confirmed
Absent Present
5.
Test for Sulphide
1 gram of the substance is
treated with 2 ml of
concentrated Hydrochloric
acid
Colourless, rotten
egg smelling gas
turning lead
acetate paper
black on warming
evolves
Presence
of
Sulphide is
confirmed
Present Absent
6.
Test for Nitrate
1 gram of the substance is
heated with copper turnings
and concentrated sulphuric
acid and viewed the test
tube vertically down
Copious
evolution of
reddish brown
gas
Presence
of Nitrate Absent Absent
7.
Test for Flouride and
Oxalate
a.2 ml of the extract is
added with 2 ml of dilute
acetic acid and 2 ml of
Calcium Chloride solution
and heated
Cloudy
appearance /
white precipitate
is obtained
Presence
of Flouride
and
Oxalate
Present
Present
8.
8.Test for Nitrite
3 drops of the extract is
placed on a filter paper, on
that 2 drops of dilute acetic
acid and 2 drops of dilute
Benzidine solution is
placed.
No characteristic
changes
Absence
of Nitrite Absent Absent
9
Test for Borate
2 pinches of the substance
is made in to paste by using
sulphuric acid and added 95
% and introduced in to blue
flame
Green tinged
flame is seen
Presence
of Borate
is
confirmed
Absent Absent
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S.no Experiment Observation Inference Rajarajeswaram
Madhana
Biravam
1.
Test for Lead
2 ml of the extract is
added with 2 ml of
potassium iodide solution
Yellow precipitate
soluble in hot water
and reappearing as
golden yellow
spangles on cooling
is obtained
Presence of
lead is
confirmed
Absent Absent
2.
Test for Copper
a.one pinch of the
substance is made in to
paste with concentrated
hydrochloric acid in watch
glass and introduced in to
the non luminous part of
the flame
b.2 ml of the extract is
added with excess of
Ammonia solution
Bluish green
colored flame is
obtained
Bluish precipitate
or deep blue
colored solution is
obtained
Presence of
Copper
Presence of
Copper is
confirmed
Absent
Absent
Present
Present
3.
Test for Aluminium
To 2 ml of the extract
Sodium Hydroxide
solution is added in drops
to excess
White precipitate
soluble in excess of
Sodium Hydroxide
is obtained
Presence of
Aluminium is
confirmed Absent Absent
4.
Test for Iron
a.To 2 ml of the extract 2
ml of Ammonium Thio
cyanate solution is added
b.To 2 ml of the extract 2
ml of Ammonium
Thiocyanate solution and
2 ml of concentrated
Nitric acid is added
Blood red color is
obtained
Blood red color is
obtained
Presence of
Ferric Iron is
confirmed
Presence of
Ferrous iron
is confirmed
Absent
Absent
Absent
Absent
5.
Test for Zinc
To 2 ml of the extract
Sodium hydroxide
solution is added in drops
to excess and dilute
ammonium chloride is
added.
White precipitate
soluble in excess of
Sodium Hydroxide
is obtained
Presence of
Zinc is
confirmed
Present Absent
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6.
Test for Calcium
2 ml of the extract is
added with 2 ml of 4 %
ammonium oxalate
solution
Cloudy appearance
/ white precipitate
is obtained
Presence of
Calcium is
confirmed
Present Present
7.
Test for Magnesium
To 2 ml of the extract
Sodium Hydroxide
solution is added in drops
to excess
White precipitate
insoluble in excess
of Sodium
Hydroxide solution
is obtained
Presence of
Magnesium is
confirmed
Present
Absent
8.
Test for Ammonium
To 2 ml of the extract
few ml of Nessler’s
reagent and excess of
Sodium Hydroxide
solution are added
Reddish brown
precipitate is
obtained
Presence of
Ammonium is
confirmed
Absent Absent
9.
Test for Pottasium
A pinch of the
substance is treated with w
2 ml of Sodium Nitrate
solution and then treated
with 2 ml of Cobalt Nitrite
in 30 % glacial acetic acid
Yellowish
precipitate is
obtained
Presence of
Potassium is
confirmed
Absent Absent
10.
Test for Sodium
2 pinches of the
substance is made in to
paste by using
Hydrochloric acid and
introduced in to blue
flame
Yellow flame is
seen
Presence of
Sodium is
confirmed
Present Absent
11.
Test for Mercury
2 ml of the extract is
treated with 2 ml of
Sodium Hydroxide
solution
Yellow precipitate
is obtained
Presence of
Mercury is
confirmed
Present Present
12.
Test for Arsenic
2 ml of the extract is
treated with 2 ml of Silver
Nitrate Solution
Yellow precipitate /
Brownish red
precipitate is
obtained
Presence of
Arsenic is
confirmed Present Present
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s.no Experiment Observation Inference Rajarajes
waram
Madhana
Biravam
1. Test for Starch
2 ml of the extract is
treated with weak Iodine
solution
Absent Absent
2. Test for Reducing sugar
5 ml of Benedict’s
qualitative solution is
taken in a test tube and
allowed to boil for 2
minutes and 8 – 10 drops
of the extract is added and
again it is boiled for 2
minutes. The color
changes are noted
Change in color
light green / dark
green / brick red
is obtained
Presence of
reducing
sugar
Present Absent
3. Test for Alkaloids
a. 2 ml of the extract is
treated with 2 ml of
potassium iodide solution
b.2 ml of the extract is
treated with 2 ml of picric
acid
c.2 ml of the extract is
treated with 2 ml of
Phosphotungstic acid
Red color
develops
Yellow color
develops
White precipitate
develops
Presence of
Alkaloids
Presence of
Alkaloids
Presence of
Alkaloids
Present
Present
Present
Absent
Absent
Absent
4. Test for Tannic Acid
2 ml of the extract is
treated with 2 ml of Ferric
Chloride solution
Black precipitate
is obtained
Presence of
Tannic acid
Absent Absent
5. Test for Unsaturated
Compound:
2 ml of extract treated
with 2 ml of dilute
Potassium permanganate
solution is added.
Potassium
permanganate is
not decolorized.
Absence of
Unsaturated
Compound
Present Absent
6. Test for Albumin
2 ml of the extract is
added with 2 ml of
Esboch’s reagent
Yellow color
precipitate is
obtained
Presence of
Albumin
Absent Absent
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PHYSICO-CHEMICAL ANALYSIS
The sample of Rajarajeswara kuligai and Madhana biravam was analyzed as per
the standard guidelines.
Physico-chemical parameters
The procedures recommended in WHO guidelines (Anonymous, 1998) were
followed to determine loss on drying at 105°C, total ash, acid-insoluble ash and solubility
in alcohol and water
Loss on Drying of the sample at 1050C
About 4 g of the plant powder was accurately weighed in a tarred 100 ml beaker.
It was heated in a hot air oven at 105 C for 5 hours. The beaker was cooled in a esiccator
and weighed. The procedure was repeated to get constant weight. The percentage of loss
in weight of the sample was calculated.
Calculation
Loss in weight of the sample
Percentage of loss on drying at 105 0C = - ------------------------------------- x 100
Weight of the sample taken
Total ash content
About 4 g of the plant powder was accurately weighed in a previously ignited and
tarred silica dish. The sample was ignited in a muffle furnace at 600°C to convert
completely into ash. The dish was cooled in a desiccator and weighed. The procedure was
repeated to get constant weight. The percentage of total ash was calculated.
Calculation
Weight of the ash
Percentage of total ash = ------------------------------------------ x 100
Weight of the sample taken
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Acid insoluble ash
To the dish containing total ash, 15 ml of 1: 5 hydrochloric acid was added thrice
and gently heated for 5 minutes and filtered through Whatman No: 41 filter paper. The
filter paper along with the insoluble matter was transferred to silica dish and ignited in a
muffle furnace at 600°C to get constant weight. The dish was cooled in desiccator and
weighed. The percentage of acid insoluble ash was calculated.
Calculation
Weight of the acid insoluble residue
Percentage of acid-insoluble ash = ------------------------------------------------- x 100
Weight of the sample taken
Water soluble extractive
About 4 g of the plant powder was accurately weighed in glass stoppered 250 ml
flask. 100 ml of distilled water was added and shaken occasionally for 6 hours and then
allowed to stand for 18 hours. The solution was filtered using Whatman No:1 filter paper.
25 ml of the filtrate was pipetted out into a preweighed 100 ml beaker. The filtrate was
evaporated on a water bath and the beaker was dried in a hot air oven at 105°C for 6
hours. It was cooled in a desiccator and weighed. The percentage of the water soluble
extractive was calculated.
Calculation
Weight of the extract 100
Percentage of water soluble extractive = -------------------------------- x --------- x 100
Weight of the sample taken 25
Alcohol soluble Extractive
About 4 g of the plant powder was accurately weighed in glass stoppered 250 ml
flask. 100 ml of distilled alcohol (95%) was added and shaken occasionally for 6 hours
and then allowed to stand for 18 hours. The solution was filtered using Whatman No: 1
filter paper. 25 ml of the filtrate was pipetted out into a preweighed 100 ml beaker. The
filtrate was evaporated on a water bath and the beaker was dried in a hot air oven at
105°C for 6 hours. It was cooled in a desiccator and weighed. The percentage of the water
soluble extractive was calculated.
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Calculation
Weight of the extract 100
Percentage of alchohol soluble extractive = ------------------------------------ x --------- x 100
Weight of the sample taken 25
Estimation of the heavy metals.
The procedures recommended for analysis of Heavy Metals like Lead, Cadmium,
Mercury and Arsenic in WHO, 1998 and AOAC, 2005.
Instrument & Operating parameter
Thermo Fisher M Series, 650902 V1.27 model atomic absorption spectrometer
(AAS) was used in the analysis. The operating parameters for:
Instrument details:
Thermo Fisher M Series, 650902 V1.27 model Atomic Absorption Spectrometer
(AAS) was used for the analysis. The operating parameters:
Lead and Cadmium:
Instrument technique : Flame technique
Wavelength (Lead) : 217 nm
Wavelength (Cadmium) : 228.8 nm
Slit width : 0. 5 mm
Lamp current (Pb) : 4.0 mA
Lamp current (Cd) : 3.0 mA
Carrier gas and flow rate : Air and Acetylene, 1.1 L/min
Flow rate : 2 ml/min
Mercury:
Instrument technique : Cold vapour technique
Wavelength : 253.7 nm
Slit width : 0. 5 mm
Lamp current : 3.0 mA,
Carrier gas and flow rate : Argon, 1.1 L/min
Flow rate : 5ml/min
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Arsenic:
Instrument technique : Flame vapour technique
Wavelength : 193.7 nm
Slit width : 0. 5 mm
Lamp current : 6.0 mA,
Carrier gas and flow rate : Acetylene, Argon, 1.1 L/min
Flow rate : 5ml/min
The Hallow cathode lamp for Pb, Cd, Hg and As analysis were used as light
source to provide specific wavelength for the elements to be determined.
Preparation of sample solutions
Cadmium and Lead
Take 5 g of the sample in a pre-weighed silica dish. Add 5 ml of digestion mixture
(Nitric acid: Perchloric acid 2 : l) and heat slowly to 100°C and maintain at this
temperature for 3 hours. Raise the temperature very slowly to 240°C avoiding losses due
to possible violent reactions especially in the temperature range of 160°C to 200°C an
maintain at this temperature till it becomes dry (approximately 4 hours). Dissolve the
remaining inorganic residue in 20 ml nitric acid make it up to 100 in a volumetric flask
with distilled water.
Mercury
Weigh 5 gms of the sample into a digestion flask. Add 25 ml of 9M sulphuric
acid, 20ml of 7M Nitric acid, 1 ml 2% Sodium Molybdate solution and 5-6 boiling
chips.Connect the condenser and apply gentle heat for 1 hour. Allow it cool. Add 20
mlNitric acid-Perchloric acid (1:1) through the condenser. Boil until white fumes appear
in the flask. Cool and add cautiously 10 ml of water through the condenser. Again boil the
solution for l0 minutes. Cool and wash the condenser with three 15 ml portions of water,
cool the solution to room temperature. Transfer the digest to 100 ml volumetric flask and
make up to the mark with deionised water.
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Arsenic
Take 5 g of the sample in kjeldal flask and add 10 ml of de-ionized water. 25 ml
of concentrated Nitric acid and 20 ml of Concentrated Sulphuric acid. Heat cautiously so
that no excessive foaming takes place. Gradually add concentrated Nitric acid drop by
drop until all the organic matter is destroyed. If darkening of the solution is observed, add
some more Concentrated Nitric acid with continuous heating until a clear solution is
obtained. Cool and add 30 ml of de-ionised water and 10 ml of Ammonium oxalate
(25 g/l) solution. Heat again until copious white fume is evolved. Cool and make up to
100 ml in a volumetric flask with de-ionized water.
Analysis of Aflatoxins
The procedures recommended for analysis of Aflatoxins B1, B2, G1 and G2 as per
Official Analytical Methods of the American Spice Trade Association (ASTA), 1997.
Instrument details:
Thermo Fisher High Performance Liquid Chromatography (HPLC) was used in
the Aflatoxins analysis. The operating parameters:
Column  : Ultra C18, 250 X 4.6 mm, 5 µm particles
Mobile Phase  : Water: Acetonitrile: Methanol (65: 22.5: 22.5)
Flow rate  : 1 mL/min.
Temperature  : 35º C
Detector  : Fluorescence detector at 360 nm
Injection  : 20 µl (Aflatoxins mixture and Sample)
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RESULTS AND DISCUSSION
Evaluation of tablets
The formulated tablets Rajarajeswara kuligai and Madhana biravam were
evaluated for the physicochemical characteristics.
Uniformity of weight
Uniformity of weight of Rajarajeswara kuligai was observed as 110mg and
Madhana biravam was observed as 55mg
1. Physico-chemical values
S. No. Parameter RajaRajeswaram Madhanabiravam
1. Loss on drying at 105oC 6.37 % 4.19 %
2. Ash values
a. Total Ash
b. Acid Insoluble Ash
58.62 %
3.78 %
87.93 %
15.34 %
3. Extract Values
a. Alcohol
b. Water
5.16 %
26.32 %
8.70 %
49.45 %
2. Analysis of Heavy Metals
S. No. Name of the
Element RajaRajeswaram
Madhana
biravam Permissible Limit
1 Lead 0.1635 ppm 0.1977 ppm 10 ppm (WHO)
2 Cadmium Not Detected Not Detected 0.3 ppm (WHO)
3 Mercury 0.8024 ppm 0.7137 ppm
1 ppm (API, 2008)
4 Arsenic 0.1732 ppm 0.1836 ppm
3 ppm (API, 2008)
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3. Analysis of Aflatoxins
4.Analysis of Microbial Load
The procedures recommended for analysis of Microbial Load as per WHO, 1998.
S.
No. Parameters RajaRajeswaram
Madhana
biravam
Permissible
Limit for
Internal use
1
Total Bacterial Count
(TBC)
10 CFU/g 10 CFU/g 105 CFU/g
2 Total Fungal Count
(TFC)
10 CFU/g 10 CFU/g 103 CFU/g
3 Enterobacteriaceae Absent Absent 103 CFU/g
4 Escherichia coli Absent Absent 10 CFU/g
5 Salmonella Spp Absent Absent Absent
6 Staphylococcus aureus Absent Absent Absent
S. No. Aflatoxins RajaRajeswaram Madhana biravam
1 B1 Not detected Not detected
2 B2 Not detected Not detected
3 G1 Not detected Not detected
4 G2 Not detected Not detected
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FTIR STUDY
In order to prepare a KBr pellet, follow the procedure given below:
Sample/KBr ratio
The concentration of the sample in KBr should be in the range of 0.2% to 1%. The
pellet is much thicker than a liquid film, hence a lower concentration in the sample is
required (Beer's Law). Too high a concentration usually causes difficulties obtaining clear
pellets. The IR beam is absorbed completely, or scattered from the sample which results
in very noisy spectra.
Sample preparation
Although a homogeneous mixture will give the best results, excessive grinding of
the potassium bromide is not required. The finely powdered potassium bromide will
absorb more humidity (it is hygroscopic) from the air and therefore lead to an increased
background in certain ranges. Make sure to work fast. Transfer some KBr out of the oven
(ATTENTION: the oven is at 100 oC - you can easily burn yourself!) into a mortar. Add
about 1 to 2 % of your sample, mix and grind to a fine powder. For very hard samples,
add the sample first, grind, add KBr and then grind again.The sample must be very finely
ground as in the Nujol mulling technique to reduce scattering losses and absorption band
distortions.
Take two stainless steel disks out of the desiccator. Place a piece of the precut
cardboard (in the tin can next to the oven) on top of one disk and fill the cutout hole with
the finely ground mixture. Put the second stainless steel disk on top and transfer the
sandwich onto the pistil in the hydraulic press. With a pumping movement, move the
hydraulic pump handle downward. The pistil will start to move upward until it reaches
the top of the pump chamber. Then, move the pump handle upwards and pump until the
pressure reaches 20,000 prf. Leave for a few seconds and with the small lever on the left
side, release the pressure (hold until the sample and pistil are all the way down). Remove
the disks and pull apart. Remove the film, which should be homogenous and transparent
in appearance. Insert into the IR sample holder and attach with scotch tape. Run the
spectrum.
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After use, the mortar and pistil should be cleaned with acetone and double distilled water,
and be put back on top of the oven for drying.
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2371.2
2345.8
2139.6
1626.6
1457.6 1155.5
1115.7 876.0
830.7
676.3
613.9
468.3
Rajarajeswarm pk
REF 4000 97.9 2000 97.5 600
3404.0 3.1 2926.5 24.6 2371.2 85.6 2345.8 91.0 2139.6 93.8
1626.6 27.8 1457.6 29.2 1155.5 29.8 1115.7 31.7 876.0 33.5
830.7 25.7 676.3 83.4 613.9 87.6 468.3 80.1
END 14 PEAK(S) FOUND
IR Spectra – Interpretation:
The IR spectrum showed the presence of hydroxyl group (3404 cm-1), ester
carbonyl (2926.5 cm-1), trisubstituted double bond (1626.6 and 830.7 cm-1), aromatic
function (1457.6 cm-1) and C-O stretching (1155.5 cm-1).
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REF 4000 100.0 2000 90.1 600
3904.0 79.8 3483.7 3.1 2928.0 51.9 2360.4 86.3 2118.1 87.4
1624.4 43.1 1118.1 48.0 621.9 71.7
END 8 PEAK(S) FOUND
IR Spectra – Interpretation:
The IR spectrum showed the presence of hydroxyl group (3483.7 cm-1), ester
carbonyl (2928 cm-1), trisubstituted double bond (1624.4 cm-1) and C-O stretching
(1118.1 cm-1).
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SOPHISTICATED ANALYTICAL INSTRUMENT FACILITY
ANNA UNIVERSITY,CHENNAI
SEM-METHODOLOGY
An SEM is essentially a high magnification microscope, which uses a focussed
scanned electron beam to produce images of the sample, both top-down and, with the
necessary sample preparation, cross-sections. The primary electron beam interacts with
the sample in a number of key ways:-
· Primary electrons generate low energy secondary electrons, which tend to
emphasize the topographic nature of the specimen.
· Primary electrons can be backscattered which produces images with a high
degree of atomic number (Z) contrast.
· Ionized atoms can relax by electron shell-to-shell transitions, which lead to
either X-ray emission or Auger electron ejection. The X-rays emitted are
characteristic of the elements in the top few m of the sample.
SAMPLE PREPARATION:
Sample preparation can be minimal or elaborate for SEM analysis, depending on
the nature of the samples and the data required. Minimal preparation includes acquisition
of a sample that will fit into the SEM chamber and some accommodation to prevent
charge build-up on electrically insulating samples. Most electrically insulating samples
are coated with a thin layer of conducting material, commonly carbon, gold, or some
other metal or alloy. The choice of material for conductive coatings depends on the data
to be acquired: carbon is most desirable if elemental analysis is a priority, while metal
coatings are most effective for high resolution electron imaging applications.
Alternatively, an electrically insulating sample can be examined without a conductive
coating in an instrument capable of "low vacuum" operation.
 The SEM is carried out by using FEI-Quanta FEG 200-High Resolution
Instrument.
Resolution : 1.2 nm gold particle separation on a carbon substrate
Magnification: From a min of 12x to greater than 1, 00,000 X
Application : To evaluate grain size, particle size distributions, material homogeneity
and inter metallic distributions.
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Sample preparation:
Sample preparation can be minimal or elaborate for SEM analysis, depending
on the nature of the samples and the data required. Minimal preparation includes
acquisition of a sample that will fit into the SEM chamber and some accommodation to
prevent charge build-up on electrically insulating samples. Most electrically insulating
samples are coated with a thin layer of conducting material, commonly carbon, gold, or
some other metal or alloy. The choice of material for conductive coatings depends on the
data to be acquired: carbon is most desirable if elemental analysis is a priority, while
metal coatings are most effective for high resolution electron imaging applications.
Alternatively, an electrically insulating sample can be examined without a conductive
coating in an instrument capable of "low vacuum" operation.
Drug. Extract
Solvents
Colour Nature SEM
Particle size in
micron
Rajarajeswaram Water Black Solid 10-15
Madhanabiravam Water Pale
brown
Solid 1-5
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TOXICOLOGICAL EVALUVATION OF RAJARAJESWARAM AND
MADHANA BIRAVAM
Introduction
Paracelsus (1493-1541) stated that “All substances are poisons; The right dose
differentiates a poison and a remedy” This concept is the fundamental principle of
toxicology and hazard assessment.
Medicinal plants play a key role in the human health care because of their
efficacy,safety and lesser adverse effects. When herbal drugs are used as a therapeutic
substance for treating various ailments, it becomes an essential requirement to fulfill the
guidelines formulated by world health organization (WHO). WHO guidelines have given
one of the important criteria to establish the safety profile of the herbal preparations.
Hence in the present study the Rajarajeswaram and Madhana biravam tablets
were subjected to acute and repeated dose oral toxicity evaluation in order to assess,
whether the extracts have any adverse affects or toxic manifestations for long term use.
Toxicological study results play the important safety assessment of pharmaceuticals, food
additives, pesticides and other chemicals.
In the present toxicological evaluation, the Rajarajeswaram and Madhana
biravam were studied in (1)acute oral toxicity study as per the OECD guidelines-423 and
(2) 28 days repeated oral dose toxicity study as per OECD Test guidelines 408 . 
Materials and Methods
Animals
Wistar albino rats of either sex (140 – 200 gm) were obtained from The King
Institute of Preventive Medicine, Guindy, Chennai-600 032. The animals were kept in
Animal House, National Institute of Siddha, Chennai-47 and kept in polypropylene cages
at 22±2oC with relative humidity 30-70% under 12 hr light and 12 hr dark cycles. They
were fed with standard laboratory animal feed (Rodent pelleted feed, Nutrilab rodent,
India) and tap water ad libitum.
The toxicological protocols were approved by the
IAEC of CPCSEA. (1248/ac/09/CPCSEA/4-10A/2011), (1248/ac/09/CPCSEA/4-
10B/2011)
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Preparation of the drug for the experimental study
The Rajarajeswaram and Madhana biravam were administered in the form of
suspension in water with 30% Twin 80 as suspending agent.
Acute toxicity
Acute oral toxicity study was performed as per OECD-423 guidelines(acute toxic
method). Wistar albino rats (n = 3) of female sex selected by random sampling technique
was used for the study. The animals were kept fasting for overnight providing only water,
after which the Rajarajeswaram and Madhana biravam was administered orally at the
dose level of 5 mg / kg body weight by intragastric tube and observed for 14 days. If
mortality was observed in 2-3 animals, then the dose administered was assigned as toxic
dose. If mortality was observed in 1 animal, then the same dose was repeated again to
confirm the toxic dose. If mortality was not observed, the procedure was repeated for
further higher doses such as 50, 300 and 2000 mg / kg body weight.
The animals were observed continuously for the first 4 h and then each hour for
the next 24 h and at 6 hourly intervals for the following 48 h after administering of the
test drug, to observe any death or changes in general behaviour and other physiological
activities. Single animals are dosed in sequence usually at 48 h intervals. However, the
time interval between dosing is determined by the onset, duration, and severity of toxic
signs. Treatment of an animal at the next dose was delayed until one is confident of
survival of the previously dosed animal.
Observation of toxicity signs:
General behavior, respiratory pattern, cardiovascular signs, motor activities,
reflexes, change in skin and fur, mortality and the body weight changes were monitored
daily. The time of onset, intensity, and duration of these signs, if any, was recorded.
28 days repeated oral dose toxicity study
Experimental protocol for 28 days repeated dose study
The following experimental protocol was used to assess the repeated dose oral
toxicity study (28 days) of Rajarajeswaram and Madhana biravam in wistar albino rats
of either sex .The animals were divided into four groups of six animals each, 3 males and
3 females. 3.96mg,19.8mg and 39.6
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Group I - Animals received Rajarajeswaram Therapeutic Dose (TD) (3.96mg) daily for
28 days
Group II - Animals received Rajarajeswaram 5 X Therapeutic Dose (TD) (19.8mg)daily
for 28 days.
Group III - Animals received Rajarajeswaram 10 X Therapeutic Dose (TD) (39.6 mg)
daily for 28 days.
Group IV- Control animals received Tirikaduku kudineer (1ml /kg/po) daily for 28 days.
Body weight, food and water intake were recorded at weekly intervals with
simultaneous observation for toxic manifestation and mortality, if any. At the end of 28
days treatment, all animals were sacrificed by cervical decapitation. Blood was collected
through retro-orbital puncture and was used for biochemical estimation and hematological
studies. Sections of liver, kidney, lungs, heart, stomach and spleen were dissected out and
kept in 10 % formalin for histopathological studies.
Group I - Animals received Madhana biravam Therapeutic Dose (TD) (1.98mg) daily
for 28 days
Group II - Animals received Madhana biravam 5 X Therapeutic Dose (TD) (9.9mg )
daily for 28 days.
Group III - Animals received Madhana biravam 10 X Therapeutic Dose (TD) (19.8 mg)
daily for 28 days.
Group IV- Control animals received Tirikaduku kudineer 1ml daily for 28 days.
Body weight, food and water intake were recorded at weekly intervals with
simultaneous observation for toxic manifestation and mortality, if any. At the end of 28
days treatment, all animals were sacrificed by cervical decapitation. Blood was collected
through retro-orbital puncture and was used for biochemical estimation and hematological
studies. Sections of liver, kidney, lungs, heart, stomach and spleen were dissected out and
kept in 10 % formalin for histopathological studies.
Statistical analysis
The data were expressed as mean ± SEM. Results were analysed statistically by
One-Way ANOVA followed by Tukey’s multiple comparison using SPSS software
student’s version. The difference was considered significant if p<0.05.
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RESULTS AND DISCUSSION
Toxicological evaluvation of Madhana biravam
Results and Discussion
Acute toxicity study Madhana biravam tablet did not produce any toxic symptoms
or mortality at the dose level of 2000 mg/kg/po in rats and hence the drugs were
considered to be safe for pharmacological study. According to acute toxic class method
(OECD – 423 guidelines) the LD 50 dose of 2000 mg/kg and above is categorized as
(X ‘unclassified).
28 days repeated oral dose toxicity study
From the observation of the 28 days repeated oral dose study of Madhana
biravam at the dose of 1.98mg,9.9mg and 19.8 mg did not produce any significant
changes in the body weight, food and water intake, No mortality was observed on 1st,
2nd, 3rd and 4th week in both male and female animals of Group I, Group II and Group
III and IV. Generally changes in body weight have been used to access the course of the
disease and the response to the therapy of drugs and also they indicate the adverse effects
of drugs . No significant changes were observed in the haematological parameters like
Hb, RBC, WBC, clotting time and differential leucocyte counts for Madhana biravam
treated groups shows the levels of blood glucose, cholesterol, BUN, creatinine
respectively. There were no significant changes in any of the hematological parameters in
Madhana biravam treated group compared with the control groups. The blood glucose
level, which remained constant in all the groups of animals, shows the normoglycemic
activity of the Madhana biravam . Determination of BUN and serum creatinine shows
that the Madhana biravam did not produce any renal dysfunction, as increase in the
above parameters reveals the impaired renal function or acute renal failure .
AST, ALT, ALP and total bilirubin are good indices of liver function indicate that
there were no significant changes in the enzyme levels, when compared with the control
animals. Hence the Madhana biravam did not induce any toxicity to the liver and kidney.
Determination of kidney function tests shows that the did not produce any renal
dysfunction, as increase in the above parameters reveals the impaired renal function or
acute renal failure. Hence the Madhana biravam did not induce any toxicity to the liver
and kidney. This was further confirmed by the histopathological assessment of these
organs.
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Toxicological evaluvation of Rajarajeswaram
Results and Discussion
Acute toxicity study Rajarajeswaram tablet did not produce any toxic symptoms
or mortality at the dose level of 300 mg/kg/po in rats but it produce toxic symptoms and
mortality at the dose level of 2000 mg/kg/po in rats ,all three rats were died in 48 hours
and Observed of toxicity signs were lethargy, respiration rate reduced, nasal discharge,
mild ataxia, gait abnormal mild catalepsy, scratching, diarrhoea, water intake was more
and food intake was less, hair straightening, tremor and in necropsy spleen swelling,
kidney swelling ,heart normal, both lung reddish colour ,liver mild discolouration, both
lung congested, one lung more stasis seen and trachea normal, According to toxic class
method (OECD – 423 guidelines) theLD 50 dose of 500 mg/kg and above is categorized
as (X ‘unclassified).
28 days repeated oral dose toxicity study
From the observation of the 28 days repeated oral dose study of Rajarajeswaram
at the dose of 3.96mg,19.8mg and 39.6 mg did not produce any significant changes in
the body weight, food and water intake, No mortality was observed on 1st, 2nd, 3rd and
4th week in both male and female animals of Group I, Group II and Group III and IV.
Generally changes in body weight have been used to access the course of the disease and
the response to the therapy of drugs and also they indicate the adverse effects of drugs.
No significant changes were observed in the haematological parameters like Hb, RBC,
WBC, clotting time and differential leucocyte counts for Rajarajeswaram treated groups
shows the levels of blood glucose, cholesterol, BUN, creatinine respectively. There were
no significant changes in any of the hematological parameters in Rajarajeswaram treated
group compared with the control groups. The blood glucose level, which remained
constant in all the groups of animals, shows the normoglycemic activity of the
Rajarajeswaram. Determination of BUN and serum creatinine shows that the
Rajarajeswaram did not produce any renal dysfunction, as increase in the above
parameters reveals the impaired renal function or acute renal failure. AST, ALT, ALP and
total bilirubin are good indices of liver function indicate that there were no significant
changes in the enzyme levels, when compared with the control animals. Hence the
Rajarajeswaram did not induce any toxicity to the liver and kidney. Determination of
kidney function tests shows that the did not produce any renal dysfunction, as increase in
the above parameters reveals the impaired renal function or acute renal failure. Hence the
Rajarajeswaram did not induce any toxicity to the liver and kidney. This was further
confirmed by the histopathological assessment of these organs.
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1.Mortality
Observation of 28days sub acute toxicity study of Madhana biravam and
Rajarajeswaram
Treatment
Male /Female
1st week 2nd week 3rd week 4th week
Group I nil nil nil nil
Group I nil nil nil nil
Group III nil nil nil nil
Group IV nil nil nil nil
2.Body weight (gram) observation of 28days sub acute toxicity study of Madhana
biravam and Rajarajeswaram
Treatment 1st week 2nd week 3rd week 4th week
Group I 160.66±6.91 150±9.65 161.33±8.73 168.8±5.40
Group I 165.25 ±10.82 169.33±12.51 174.5±10.80 172.33±7.31
Group III 169.16±9.19 169.66±9.87 173±9.31 169±8.46
Group IV 168.83±6.79 174±5.93 174.66±8.75
172.83±6.11
Values are mean ±SD of respective group of animals.
70
3. Hematological parameters of 28 days sub-acute toxicity study treatment of
Madhana biravam
S.No Parameters
Units
Group I Group II Group III Group III
1 WBC 103/mm3 27.56±4.11 24.33 4.77 24.76±5.34 33.18±9.60
2 Lymphocyte
s% % 64.78±5.90 60.97±10.34 65.39±2.85
67.58±3.33
3 Monocytes % 6.74± 0.90 6.80± 1.55 6.34±1.64 4.70± 1.09
4 N/Gr % 25.36±3.07 26.03± 6.44 24.51±4.59 26.16±4.87
5 RBC 106/mm3 7.06± 0.65 7.37 ±0.59 7.01±0.52 7.40± 0.62
6 Hgb g/dl 15.33±1.06 14.95± 1.15 14.55±1.20
15.41±0.80
Values are mean ±SD of respective group of animals.
4. Biochemical parameters of plasma on 28 days sub-acute toxicity study treatment
of Madhana biravam
S.no Parameters Units GroupI GroupII GroupIII GroupIV
1. Albumin g/ml 4.76 ±0.24 4.58 ±0.37 4.63 ±0.44 5.44±1.2
2. Bilirubin mg/ml 0.32 ±0.06 0.32 ±0.08 0.29 ±0.19 0.26 ±0.15
3. Cholesterol mg/ml 42.17±5.41 41.55±6.77 44.42±5.62 42.80±6.41
4. Creatinine mg/ml 0.65 ±0.03 0.67 ±0.04 0.65 ±0.04 0.65 ±0.03
5. Glucose mg/ml 79.71±13.88 87.45±12.17 87.40±8.21 90.79±11.37
6. Protein g/ml 6.32 ±0.29 6.25 ±0.41 6.47 ±0.25 6.23 ±0.28
7. Triglycerides mg/ml 96.46±21.24 99.10±31.56 73.58±16.12 65.30±22.07
8. Urea mg/ml 27.04 ±3.12 26.53 ±2.74 34.83 ±3.17 29.38 ±3.79
9. AST U/L 96.80±13.64 106.81±17.08 107.40±17.74 109.19±16.42
10. ALT U/L 39.06 ±9.60 41.65 ±8.79 43.04 ±5.64 39. 17±7.82
11. ALP U/L 337.50±102.81 408.02±118.38 369.91±75.68 325.6±101.09
Values are mean ±SD of respective group of animals.
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5. Hematological parameters of 28 days sub-acute toxicity study treatment of
Rajarajeswaram
S.N
o Parameters
Units Group I Group II Group III Group IV
1 WBC 10
3/mm
3
8324±312.
4
8417±368.
1
8542±225.
2
7882±361.
4
2 Lymphocytes
% % 43.26±2.44 43.28±2.56 44.34±2.2 44.25±2.45
3 Monocytes % 4.1±0.31 4.2±0.4 4.1±0.4 4.2±0.30
4 N/Gr % 42.36±2.78 43.00±3.1 42.45±3.0 45.10±2.18
5 RBC 10
6/mm
3 5.12±0.35 5.15±0.52 5.44±0.36 5.01±0.32
6 Hgb g/dl 13.99±0.86 14.2±1.4 14.00±1.2 13.47±0.78
Values are mean ±SD of respective group of animals.
6.Biochemical parameters of plasma on 28 days sub-acute toxicity study treatment
of Rajarajeswaram
S.no Parameters Units GroupI GroupII GroupIII GroupIV
1. Albumin g/ml 2.72±0.05 2.70±0.05 2.75±0.05 2.81±0.07
2. Bilirubin mg/ml 0.1±0.02 0.1±0.03 0.1±0.04 0.1±0.03
3. Cholesterol mg/ml 57.24±5.52 56.42±5.44 56.19±4.92 56.10±5.10
4. Creatinine mg/ml 0.93±0.04 0.92±0.04 0.90±0.04 0.91±0.05
5. Glucose mg/ml 80.02±4.48 79.75±3.88 78.62±4.64 82.22±4.10
6. Protein g/ml 7.48±0.54 7.42±0.70 7.50±0.72 7.20±0.48
7. Triglycerides mg/ml 86.38±2.45 87.42±2.21 88.30±2.58 86.38±3.44
8. Urea mg/ml 54.78±3.36 55.42±2.48 54.44±2.12 55.00±2.48
9. AST U/L 126.4±5.10 125.4±5.22 127.4±5.72 128.1±5.28
10. ALT U/L 34.48±2.99 35.00±2.46 34.92±2.75 35.14±3.15
11. ALP U/L 67.10±3.82 66.12±4.30 65.41±4.44 66.11±4.41
Values are mean ±SD of respective group of animals.
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Histopathological Evaluation of Madhana biravam
The histopathological studies of the major vital organs like liver, kidney,
heart,spleen, lungs, ovary, testis and brain were recovered from both control and
Madhana biravam treated animals. The histopathological study showed normal
architecture suggesting no detrimental changes and morphological disturbances were
caused by the daily oral administration of the Madhana biravam at the dose level of
1.98mg,9.9mg and 19.8mg for 28 days.
Histopathological studies of the Madhana biravam and vehicle treated animals
observed mild degenerative changes in liver, lung and kidney. The histopathology results
of other organs observed no abnormality detected. Histopathological study showed
normal architecture suggesting no detrimental changes and morphological disturbances
were caused by the daily oral administration of the Madhana biravam at the dose level of
1.98mg,9.9mg and 19.8mg for 28 days.
Histopathological Evaluation of Rajarajeswaram
The histopathological studies of the major vital organs like liver, kidney,
heart,spleen, lungs, ovary, testis and brain were recovered from both control and
Rajarajeswaram treated animals. The histopathological study showed normal architecture
suggesting no detrimental changes and morphological disturbances were caused by the
daily oral administration of the Rajarajeswaram at the dose level of 3.96mg,19.8mg and
39.6mg for 28 days.
Histopathological studies of the Rajarajeswaram and vehicle treated animals
observed mild degenerative changes in liver, lung and kidney. The histopathology results
of other organs observed no abnormality detected. Histopathological study showed
normal architecture suggesting no detrimental changes and morphological disturbances
were caused by the daily oral administration of the Rajarajeswaram at the dose level of
3.96mg,19.8mg and 39.6mg for 28 days.
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Histopathological observation of 28 days repeated dose study of Madhana biravam
Groups
Cytological / Histopathological findings
(liver)
Group I Mild mononuclear cell infiltration
Group I I Congestion and biliary epithelial cell
hyperplasia
Group III Sinusoidal congestion, biliary epithelial cell
hyperplasia and mononuclear cell
infiltration
Group IV Melild congestion, mild kupffer cell
hyperplasia
Histopathological observation of 28 days repeated dose study of Rajarajeswaram
Groups
Cytological / Histopathological findings
(liver)
Group I Mild mononuclear cell infiltration
Group I I Congestion and biliary epithelial cell
hyperplasia,mild degeneration of hepatocytes
and periportal mononuclear cell infiltration
Group III Congestion , mild degeneration of hepatocytes , 
very mild mononuclear cell and neutrphilic
infiltration
Group IV Melild congestion, mild kophilicupffer cell
hyperplasia
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Histopathological observation of 28 days repeated dose study of Madhana biravam
Groups
Cytological / Histopathological findings
(lung)
Group I Mild pulmonary congestion, and mild
interstitial mononuclear cell infiltration
Group I I Pulmonary congestion,
oedema,peribronchial and perivascular
mononuclear cell infiltration
Group III Pulmonary congestion, oedema,
peribronchial neutrophilic and mononuclear
cell infiltration and interstitial mononuclear
cell infiltration
Group IV Mild pulmonary congestion, and mild
peribronchial mononuclear cell
infiltration
Histopathological observation of 28 days repeated dose study of Rajarajeswaram
Groups
Cytological / Histopathological findings
(lung)
Group I Mild pulmonary congestion, and mild
interstitial mononuclear cell infiltration
Group I I Pulmonary congestion, peribronchial
mononuclear and neutrophilic infiltration
Group III Pulmonary congestion, peribronchial
mononuclear cell infiltration
Group IV Mild pulmonary congestion, and mild
peribronchial mononuclear cell
infiltration
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Histopathological observation of 28 days repeated dose study of Madhana biravam
Groups
Cytological / Histopathological findings
(spleen)
Group I Mild Congestion
Group I I Congestion and haemosidrosis
Group III Congestion and haemosidrosis
Group IV No abnormality detected
Histopathological observation of 28 days repeated dose study of Rajarajeswaram
Groups
Cytological / Histopathological findings
(spleen)
Group I Mild Congestion
Group I I Congestion and haemosidrosis
Group III Congestion and haemosidrosis
Group IV No abnormality detected
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Histopathological observation of 28 days repeated dose study of Madhana biravam
Groups
Cytological / Histopathological findings
(kidney)
Group I Mild tubular epithelial cell degeneration and
very mild interstitial
mononuclear cell infiltiration
Group I I No abnormality detected
Group III Tubular epithelial cell degeneration
Group IV Mild tubular epithelial cell degeneration and
very mild interstitial
mononuclear cell infiltiration
Histopathological observation of 28 days repeated dose study of Rajarajeswaram
Groups
Cytological / Histopathological findings
(kidney)
Group I Mild tubular epithelial cell degeneration and
very mild interstitial
mononuclear cell infiltiration
Group I I Congestion and tubular epithelial cell
degeneration
Group III  Mild tubular epithelial cell degeneration
and interstitial mononuclear cell infiltration
Group IV Mild tubular epithelial cell degeneration and
very mild interstitial
mononuclear cell infiltiration
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Histopathological observation of 28 days repeated dose study of Madhana biravam
Groups
Cytological / Histopathological findings
(stomach)
Group I No abnormality detected
Group I I No abnormality detected
Group III Glandular stomach- mononuclear cell
infiltration in the lamina propria . Non
glandular stomach-mild neutrophilic and
mononuclear cell infiltration in the lamina
propria.
Group IV No abnormality detected
Histopathological observation of 28 days repeated dose study of Rajarajeswaram
Groups
Cytological / Histopathological findings
(stomach)
Group I No abnormality detected
Group I I Glandular stomach- mild neutrophilic and
mononuclear cell infiltration in the lamina
propria . Non glandular stomach- No
abnormality detected
Group III Glandular stomach and Non glandular –
stomach- mild neutrophilic infiltration in
the lamina propria
Group IV No abnormality detected
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Histopathological observation of 28 days repeated dose study of Madhana biravam
Groups
Cytological / Histopathological findings
(Heart)
Group I No abnormality detected
Group I I No abnormality detected
Group III No abnormality detected
Group IV No abnormality detected
Histopathological observation of 28 days repeated dose study of Rajarajeswaram
Groups
Cytological / Histopathological findings
(Heart)
Group I No abnormality detected
Group I I No abnormality detected
Group III No abnormality detected
Group IV No abnormality detected
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ANTICONVULSANT ACTIVITY OF MADHANA BIRAVAM AND
RAJA RAJESWARAM AGAINST MAXIMUM ELECTROSHOCK
INDUCED SEIZURES IN MALE MICE
INTRODUCTION
Epilepsy has now become the most serious brain disorder, which accounts for
about 1% of the world’s burden diseases. A number of synthetic anti-epileptic drugs are
available in practice, however their effectiveness does not hold true with the entire range
of population suffering from this disorder. Further, a large number of drug interactions
and their side effects seen with almost all current anti-epileptic drugs make it more
difficult to attain easy control on seizures. On the other hand, herbal medicines are
widely used across the globe due to their wide applicability and therapeutic efficacy
coupled with least side effects, which in turn has accelerated the scientific research
regarding the anti-epileptic activity. There is still a need for broad spectrum acting anti-
convulsant drugs possessing multiple mechanisms of action with decreased adverse
effect, preferably originating from natural products, despite of the beneficial effect of
currently available drugs.
Recently, there is a global awareness for the study of traditional system of
medicine through application of modern scientific methods. In view of the need for safe
and effective drug, the present study was undertaken to evaluate the anti-convulsant effect
of the Madhana Biravam and Raja Rajeswaram against the seizures induced by MES
(Maximum electroshock) in male mice.
MATERIALS AND METHODS
Drugs
Phenytoin sodium 25 mg (Ranbaxy, India) was used as standard drug in this study
and was diluted to the required volume with 2% CMC in saline before use. Appropriate
vehicle (Tiri kadugu kudineer) controls were employed wherever necessary. The test
drugs also were suspended in 2% CMC to achieve stock concentration and used in this
study.
Animals
Swiss albino male mice, weighing between 25 to 30g, two months old were
obtained from animal house of Pharmacology department, Vels University. Six animals
were housed in each cage made up of polypropylene with stainless steel top grill. The
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animals were acclimatized for 7days before commencement of the experiment in standard
laboratory conditions 12±01 hour day and night rhythm, maintained at 25 ± 3°C and
50%-70% humidity as per Committee for the Purpose of Control and Supervision of
Experimental Animals (CPCSEA) guidelines. Animals were provided with balanced food
(Sai meera feeds, Bangalore) and water ad libitum. Protocol used in this study for the use
of animals was approved by the institutional animal ethics committee (Approval number:
XIII/VELS/PCOL/26/2000/CPCSEA/IAEC/08.08.2012).
Acute toxicity
The acute toxicity study of Madhana Biravam and Raja Rajeswaram up and down-
procedure at dose level of 1000 mg/kg and 2000 mg/kg body weight orally in mice as per
OECD-425 guidelines was carried out to two groups of mice, each containing six animals
and observed for mortality after 24 h.
Dose selection and Stock solution
On the basis of the acute-toxicity results the mice the maximum therapeutic dose
of Madhana Biravam and Raja Rajeswaram (MB and RR) was fixed as 250 and 500
mg/kg and 100 and 200mg/kg respectively. The test drugs were suspended in 2% CMC in
Saline with suitable concentration (200mg/ml) depending on the body weight of animals
and administered orally with the help of oral gavage sleeved to syringe. Phenytoin sodium
was selected as standard anti-epileptic drug and administered in the dose of 25 mg/kg.
Evaluation of anticonvulsant activity (MES Model)
Maximal electroshock seizure model was used in the present study to evaluate the
anti-convulsant activity of the test drugs. MES seizures were induced by an electro-
convulsiometer by delivering electroshock of 60mA current trans-auricularly for 0.2 sec
in mice using corneal electrodes. The incidence and duration of extensor tonus were
noted. In this type of seizure model, the animals were divided into six groups with six
animals and the treatment schedule is as follows.
Group I: Control group- vehicle(Tiri kadugu kudineer 1ml ) treated.
Group II: Standard (Phenytoin 25mg/kg)
Group III: Madhana biravam (250mg/kg).
Group IV: Madhana biravam (500mg/kg).
Group V: Raja Rajeswaram (100mg/kg).
Group VI: Raja Rajeswaram (200mg/kg).
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The test animals (n=6) received Madhana Biravam (250 and 500 mg/kg) and Raja
Rajeswaram (100 and 200 mg/kg) orally 30 min before application of electroshock. To
evaluate the drug effect on the seizures severity, the duration of tonic hind leg extension
and mortality due to convulsions were selected as the parameters. Each animal was
individually observed for 2 hr after MES seizures and at 24 hr for mortality. All the
experimental groups were compared with the respective controls treated with vehicle
orally.
STATISTICAL ANALYSIS
The duration of tonic hind leg extension phase of MES convulsions expressed as
the arithmetic mean ± SE and was analyzed by one-way analysis of variance (ANOVA)
followed by Dunnet’s ‘t’ test. P value less than 0.05 (P<0.05) was the criterion for
statistical significance.
RESULTS AND DISCUSSION
Epilepsy is a neurological disorder that affects a wide range of people throughout
the world. It is a disorder of brain characterized by unpredictable and periodic occurrence
of a transient alteration of behavior due to the disordered, synchronous and rhythmic
firing of populations of brain neurons. Incidence of epilepsy in developed countries is
approximately 50 per 100,000 while that of developing countries, it is 100 per 100,000. It
has been observed that the presently available antiepileptic drugs are unable to control
seizures effectively. The conventional anti-epileptic agents like Phenytoin,
Carbamazepine and Sodium valproate carry with them several serious side effects notably
neurotoxicity. As majority of anti-epileptic drugs are consumed life long, concomitant
administration of other drugs predisposes to the risk of drug interactions.
However, newer anti-epileptics like Gabapentin, Vigabatrin, Lamotrigine, etc are
used supplemental to the conventional agents. Thus, it is necessary to investigate for an
anti-epileptic agent that is highly efficacious as well as safe in items of drug related
toxicity. The aim of treating an epileptic patient is not only to abolish the occurrence of
seizures but also to lead a self sustained life. Although new anti-epileptic drugs have been
available since late 1980s, refractoriness to treatment is still an important issue in epilepsy
care. Current available anti-convulsant drugs are able to control epileptic seizures
efficiently in about 50% of the patients and lead to improvement in another 25% whereas
the remainder do not benefit significantly.
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Furthermore, undesirable side effects of the drugs used clinically often render
treatment difficult; so that a demand for new types of anti-convulsants exists. One of the
approaches to search for new anti-epileptic drugs is investigation of naturally-occurring
compounds, which belong to new structural classes. In spite of all the marvelous
advancements in modern medicine, traditional medicines have always been practiced,
because of their natural origin, easy availability, cost effectiveness, lesser side effects,
better tolerability, etc. But, because of limited documented experimental evidences
regarding their pharmacological effects, the use of traditional medicines remains
restricted to a locality/region where they are being practiced traditionally, and not
accepted globally.
Several animal models are available that could potentially be used to screen for
anti-convulsant activity, but in the present study MES induced convulsion model was
used, because this test served as "gold standard" in early stages of drug testing. Seizure
refers to a transient alteration of behaviour due to disordered, synchronous and rhythmic
firing of populations of brain neurons. Epilepsy is a disorder of brain function
characterized by periodic and unpredictable occurrence of seizures. Seizures can be “non-
epileptic” when evoked in a normal brain by treatment such as electric shock or chemical
convulsants or “epileptic” when occurring without evident provocation. Modern drug
therapy of epilepsy is complicated by the inability of drugs to control seizure in some
patients and side effects that range in severity from minimal impairment of the central
nervous system (CNS) to death from aplastic anaemia or hepatic failure. Thus its effective
and safe therapy remains a challenge.
The Madhana Biravam was found to be safe in the doses used and no abnormality
in the gross behavioral studies also no mortality were noted in the doses upto 5 g/kg
orally but and Raja Rajeswaram exhibited some severe toxic symptoms and mortality at
the dose level of 2g/kg. Hence, based on the maximum tolerable dose the one tenth and
one twentieth of this dose was considered as therapeutic dose for evaluating further
pharmacological study (Anti-convulsant activity using MES model). Since the drug is
used clinically for grandmal type of epilepsy this model was employed. This test serves to
identify the drug potency that prevents seizure spread, corresponding to generalized tonic-
clonic seizures in humans. Electroshock causes the inhibition of GABA release and this,
in turn, may inhibit GABA synthesis. All animals treated with (Tiri kadugu kudineer
)vehicle exhibited tonic hind limb extension with the electroshock of 60 mA for 0.2sec
and the duration of hind limb extension was 20.22 ± 0.29 sec. It has often been stated
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that anti-epileptic drugs that block MES-induced tonic extension act by blocking seizure
spread, moreover MES-induced tonic extension can be prevented either by drugs that
inhibit voltage dependent Na + channels or by drugs that block glutaminergic excitation
mediated by the N-methyl-d-aspartate (NMDA) receptor.
Phenytoin is effective in therapy of generalized tonic-clonic and partial seizures
have been found to show strong anti-convulsant action by increasing brain content of
Gamma-Amino Butyric Acid (GABA) in MES test.  The Madhana Biravam (250 and 500
mg/kg, orally) reduced the incidence of convulsion from 100 to 13.20 and 36.30 % and
duration of hind limb extension was reduced to 17.55 ± 0.29 sec and 12.88 ± 0.76 sec
(P<0.01) respectively, whereas phenytoin abolished the duration of hind limb extension to
11.45 ± 0.82 sec (P<0.01) But the mice treated with the Raja Rajeswaram 100 and 200
mg/kg exhibited hindleg extension for 20.00 ± 0.38 and 19.17 ± 0.55sec respectively.
Electroshock causes the inhibition of GABA release and this, in turn, may inhibit
GABA synthesis. The most popular and widely used animal seizure model is the
traditional MES test. The MES test is considered to be a predictor of likely therapeutic
efficacy against generalized tonic-clonic seizures. Thus, our results suggest that test drug
may be effective against human generalized tonic-clonic seizures. The Raja Rajeswaram
in all doses does not protect animals from seizures but duration of hindleg extension was
slightly reduced insignificantly P> 0.05 even at a dose level of 200 mg/kg. The rate of
protection was very significant at the entire Madhana Biravam treated groups when
compared to control.
In the present study treatment with MB and RRK significantly inhibited the MES-induced
seizures. Because inhibition of the MES test predicts activity against generalized tonic-clonic and
cortical focal seizures, activity against MES-induced seizures suggests that both MB and RRK
drugs are useful in suppressing generalized tonic-clonic seizures by regulating GABA-mediated
synaptic inhibition. The results were presented in Table 1.
Polypharmacy is often advocated to 30% of all epileptic patients for refractory partial or
generalized tonic-clonic seizures. However, none of the new drugs fulfills the ultimate goal of
drug treatment of epilepsy, namely complete control of seizures. Therefore, despite the beneficial
effect of the currently available drugs, there is still a need for broad-spectrum anti-convulsant
drugs possessing multiple mechanisms of action with decreased adverse effect, preferably
originating from natural products. The observation in the present study indicated that the
Madhana Biravam was without any lethal effect in a dose upto 5 g/kg and the present results
indicate that the test drugs exhibited a significant dose dependent protection against electrically
induced seizure.
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Fig. 2. Effect Of Madhana Biravam And Raja Rajeswaram On Maximal
Electroshock (MES)-Induced Seizures In Mice.
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CLINICAL STUDY
Aim
To estimate the efficacy of Rajarajeswaram and Madhana biravam in the treatment of
valippu(Epilepsy).
Study type: An open clinical trial
Study place: OPD Of Ayothidass Pandithar Hospital, National Institute of siddha,
Tambaram sanatorium, Chennai-47.
Population and sample:
20-50 age group fulfilling all the inclusion criteria and passing the exclusion criteria
mentioned below.
The sample consists of patients attending the OPD of Ayothidass Pandithar Hospital,
National Institute of siddha, Tambaram sanatorium, Chennai-47.
Sample size:
20 patients of both sex
Trial period:
30 days
SUBJECT SELECTION
As and when patients reporting at OPD of Ayothidass Pandithar Hospital with
symptoms of inclusion criteria will be subjected to screening test & documented using
screening proforma.
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INCLUSION CRITERIA
· Agegroup : 20 to 50 Years of both sex
· The symptoms of seizure especially minimum one in 30 days
· Anti –epileptic treatment has to be continued through out the trial period.
· Patient willing to sign the informed consent stating that he/she will
conscientiously stick to the treatment during 30days but can opt out of the trial
of his/her own conscious discretion.
· Patient willing to attend OPD on every 7th day.
· Patients who are willing to provide blood sample for lab investigation.
EXCLUSION CRITERIA
· Below 20 years, above 50 years.
· Severe uncontrolled epileptic patient.
·  The patient history of
o Pregnancy
o Lactation
o Malignancy
o Cardiac disease
o Renal failure
o  Liver disease
o Alcohol intoxication,
WITHDRAWAL CRITERIA
· Intolerance to the drug & development of adverse reactions during drug trial.
· Patient taking medicine irregular & defaulters.
· Patient turned unwilling to continue in the course of clinical trial.
· Increase in severity of symptoms.
· Occurrence of any serious illness.
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TEST & ASSESSMENTS
· CLINICAL ASSESSMENT
· SIDDHA ASSESSMENT
· ROUTINE INVESTIGATION
· SPECIFIC INVESTIGATION
CLINICAL ASSESSMENT
i. History of epilepsy
ii. Seizure
iii. Body,head and facial spasm.
iv. Bladder incontinence.
v. Bowel incontinence
vi. Tongue bite
vii. Limb jerking and paralysis
viii. Abnormal behavior
ix. Confusion
x. Head ache
xi. Body pain
SIDDHA ASSESSMENT
SIDDHA PARAMETERS
1.Nadi(Pulse perception)
2.Naa(Tongue)
3.Niram(Complexion)
4.Vizhi(Eyes)
5.Mozhi(Voice)
6.Parisam(Palpatory perception)
7.Malam(Bowel habits)
8.Moothiram(Urine){Neerkuri& Neikuri}
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ROUTINE INVESTIGATION
· HB (Men-12-15Gms%,Women-11.5-14gms%)
· Total WBC Count(4000-10,000cells/cumm)
· DC- Polymorphs(40-75%)
· Lymphocytes (20-40%)
· Eosinophils (1-6%)
· Monocytes (2-10%)
· Basophils (0-1%)
· Total RBC count(4-6 millions cells/cumm)
· ESR(Men 6-12mm/hr,Women 7-18mm/hr)
· B.glucose ( fasting 70-110 mg/dl& post prandial 80-140 mg/dl)
· S. total cholesterol (HDL 30-63mg/dl,LDL 130mg/dl,VLDL 40mg/dl)
RENAL FUNCTION TEST
· B.urea (16-50mg/dl)
· S. total creatinine (0.6-1.2mg/dl)
LIVER FUNCTION TEST
· SGOT(0-40U/dl)
· SGPT (0-35U/dl)
· S.alkaline phosphatase(80-290 U/dl)
· S.uric acid (Men 3-9mg/dl,Women 2.5-7.5mg/dl)
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URINE EXAMINATION
· Neerkuri & Neikuri
· Albumin
· Sugar (Fasting & post prandial)
· Deposits
STUDY:
Patients satisfying inclusion and exclusion will be selected for the study. Informed
consent will be obtained from the patients before the start of the study. The trail
drug will be issued to the patient for 7 days at a time and will be advised to attend
OPD after 7 days.
ASSESSMENT FORMS:
FORM l Screening & Selection Proforma
FORM l A History Proforma On Enrollment
FORM ll Clinical Assessment On Enrollment
FORM ll A Clinical Assessment During & After Trial
FORM lll Laboratory Investigation On Enrollment & Conclusion Of   Trial
FORM IV A Consent Form
FORM IV B Withdrawal Form
FORM IV C Patient information sheet
FORM IV D Dietary Advice Form
FORM IV E Adverse Reaction Form
ANALYSIS:
All collected data were entered in the computer and 100% data entry verified through
computer system and data analysis carried out by graph pad quick calcs.
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RESULTS OF CLINICAL TRIAL
Trial drug:Rajarajeswaram
Sex ratio of clinical study
Male patients n = 15(75%)
Female patients n = 05(25%)
Total number of patients = 20
Trial drug:Madhanabiravam
Sex ratio of clinical study
Male patients n = 14(70%)
Female patients n = 06(30%)
Total number of patients = 20
Male
75%
Female
25%
Sex Ratio
Male
70%
Female
30%
Sex Ratio
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Trial drug:Rajarajeswaram
Age wise distribution
20-30 years n =8(45%)
31-40 years n =6(33%)
41-50 years n =4 (22%)
Trial drug:Madhanabiravam
Age wise distribution
20-30 years n =9(47%)
31-40 years n =6(32%)
41-50 years n =5 (21%)
20-30
45%
31-40
33%
41-50
22%
Age
20-30
47%31-40
32%
41-50
21%
Age
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Trial drug:Rajarajeswaram
S.No Symptoms
and signs
Before
treatment
After
treatment
trail drug I
Reduction
during
Treatment
Percentage
(%)
1. Seizure 20 10 10 50%
2. Aura 09 07 02 22.22%
3. Bladder
incontinence
12 07 05 41.66%
4. Bowl
incontinence
06 04 02 33.33%
5. Tongue bite 10 06 04 40%
6. Limb jerking 20 09 11 55%
7. Abnormal
behaviour
15 08 07 46.67%
8. Confusion 18 12 06 33.33%
9. Head ache 14 04 10 71.42%
10. Body pain 20 05 15 75%
Trial drug:Madhanabiravam
S.No Symptoms
and signs
Before
treatment
After
treatment
trail drug II
Reduction
during
Treatment
Percentage
(%)
1. Seizure 20 05 15 75%
2. Aura 12 04 08 66.67%
3. Bladder
incontinence
10 05 05 50%
4. Bowl
incontinence
09 04 05 55.56%
5. Tongue bite 08 06 02 25%
6. Limb jerking 20 05 15 75%
7. Abnormal
behaviour
12 08 04 33.33%
8. Confusion 16 04 12 75%
9. Head ache 16 04 12 75%
10. Body pain 20 03 17 85%
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Comparison of signs and symptoms of Rajarajeswaram and Madhana biravam
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Trial drug:Rajarajeswaram
Seizure reduction after treatment
0
1
2
3
4
5
6
7
8
9
zero one Two Three Four Five Six and
above
Series 1
Series 2
S.NO Before treatment
number of seizure
episode in one
month
No of patients After R.R
Treatment
zero 0 08
1 One 6 03
2 Two 5 03
3 Three 02 01
4 Four 03 03
5 Five 03 01
6 Six and above 01 01
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Trial drug:Madhanabiravam
S.NO Before treatment
number of seizure
episode in one
month
No of patients After M.B
Treatment
zero 0 15
1 One 9 02
2 Two 5 00
3 Three 02 00
4 Four 01 01
5 Five 02 01
6 Six and above 01 01
0
1
2
3
4
5
6
7
8
9
10
zero one Two Three Four Five Six and
above
Series 1
Series 2
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RajaRajeswaram tablet - Paired t test results
P value and statistical significance:
  The two-tailed P value is less than 0.0001
By conventional criteria, this difference is considered to be extremely statistically
significant.
Confidence interval:
  The mean of Group One minus Group Two equals 0.84
95% confidence interval of this difference: From 0.55 to 1.13
Intermediate values used in calculations:
t = 6.0960
df = 18
standard error of difference = 0.138
Review data:
Group Group One Group Two
Mean 2.75 1.74
SD 1.65 1.76
SEM 0.37 0.40
N 20 19
Madhana Biravam tablet- Paired t test results
P value and statistical significance:
  The two-tailed P value is less than 0.0001
By conventional criteria, this difference is considered to be extremely statistically
significant.
Confidence interval:
  The mean of Group One minus Group Two equals 1.40
95% confidence interval of this difference: From 1.02 to 1.78
Intermediate values used in calculations:
t = 7.6281
df = 19
standard error of difference = 0.184
Review data:
Group Group One Group Two
Mean 2.25 0.85
SD 1.59 1.84
SEM 0.35 0.41
N 20 20
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OBSERVATIONS AND RESULTS OF CLINICAL STUDY OF
RAJARAJESWARAM AND MADHANA BIRAVAM
· Among the 20 cases treated with Rajarajeswaram 75% of patients were male and 25% of
patients were female.
· The age distribution of patients treated in this study was as following 45% were in the age
group of 20-30 years, 33% were in the age group of 31-40 years,22% were in the age
group of 41-50 years.
· Among the 20 cases, 20% of patients taking only Rajarajeswaram tablet and 80% of
patients taking Rajarajeswaram tablet along with allopathy medicine.
· From the clinical study 40% patients were reduced from seizure counts.
· 22.22% relived from aura, 40% relived from tongue bite, 55% relived from limb jerking,
46.67% relived from abnormal behavior, 33.33% relived from confusion, 71.42% relived
from headache, 75% relived from body pain.
· Some patients had complained drowsiness(40%) and low appetite(35%) and no other
adverse effects were observed.
· Among the 20 cases treated with Madhana biravam70% of patients were male and 30% of
patients were female.
· The age distribution of patients treated in this study was as following 47% were in the age
group of 20-30 years, 32% were in the age group of 31-40 years,21% were in the age
group of 41-50 years.
· Among the 20 cases 20% of patients taking only Madhana biravam tablet and 80% of
patients taking Madhana biravam tablet along with allopathy medicine.
· From the clinical study 75% patients were reduced from seizure counts. 66.67% relived
from aura, 25% relived from tongue bite, 75% relived from limb jerking, 33.33% relived
from abnormal behavior, 75% relived from confusion, 75% relived from headache, 85%
relived from body pain and no adverse effects were observed.
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DISCUSSION
· The trial drugs Rajarajeswaram and Madhana biravam have been selected for this study
to establish its efficacy in the management of valippu(Epilepsy).
· The literature evidence strongly supports the anti- epileptic activity of Rajarajeswaram
and Madhana biravam in the management of valippu(Epilepsy) from the text Siddha
vaidiya thirattu, authored by Dr.K.N.Kuppusamy mudaliyar and Dr.K.S.Uhuthamarayan,
published by Department of Indian medicine and Homeopathy, Govt of Tamilnadu.
· Chemical analysis of the trial drug Rajarajeswaram revals the presence of zinc, calcium,
magnesium,s ulphate,mercury,arsenic,chloride,oxalate and alkaloids.
· Chemical analysis of the trial drug Madhana biravam reveals the presence of copper, calcium,
magnesium, carbonate,sulphate,mercury,arsenic,chloride,and oxalate.
· The heavy metal analysis of the trial drugs Rajarajeswaram and Madhana biravam were
permissible limits. Microbial load with in normal limits and aflatoxin not detected.
· The trial drug Rajarajeswaram IR spectrum showed the presence of hydroxyl group
(3404 cm-1), ester carbonyl (2926.5 cm-1), trisubstituted double bond (1626.6 and 830.7
cm-1), aromatic function (1457.6 cm-1) and C-O stretching (1155.5 cm-1).
· The trial drug Madhana biravam IR spectrum showed the presence of hydroxyl group
(3483.7 cm-1), ester carbonyl (2928 cm-1), trisubstituted double bond (1624.4 cm-1) and C-
O stretching (1118.1 cm-1).
· Acute toxicity study Madhana biravam tablet did not produce any toxic symptoms or
mortality at the dose level of 2000 mg/kg/po in rats and hence the drugs were considered
to be safe for pharmacological study. According to acute toxic class method (OECD –
423 guidelines) the LD 50 dose of 2000 mg/kg and above is categorized as (X
‘unclassified).
28 days repeated oral dose toxicity study
· From the observation of the 28 days repeated oral dose study of Madhana biravam at the
dose of 1.98mg,9.9mg and 19.8 mg did not produce any significant changes in the body
weight, food and water intake, No mortality was observed on 1st, 2nd, 3rd and 4th week
in both male and female animals of Group I, Group II and Group III and IV. Generally
changes in body weight have been used to access the course of the disease and the
response to the therapy of drugs and also they indicate the adverse effects of drugs . No
significant changes were observed in the haematological parameters like Hb, RBC, WBC,
clotting time and differential leucocyte counts for Madhana biravam treated groups
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shows the levels of blood glucose, cholesterol, BUN, creatinine respectively. There were
no significant changes in any of the hematological parameters in Madhana biravam
treated group compared with the control groups. The blood glucose level, which remained
constant in all the groups of animals, shows the normoglycemic activity of the Madhana
biravam . Determination of BUN and serum creatinine shows that the Madhana biravam
did not produce any renal dysfunction, as increase in the above parameters reveals the
impaired renal function or acute renal failure .
· AST, ALT, ALP and total bilirubin are good indices of liver function indicate that there
were no significant changes in the enzyme levels, when compared with the control
animals. Hence the Madhana biravam did not induce any toxicity to the liver and kidney.
Determination of kidney function tests shows that the did not produce any renal
dysfunction, as increase in the above parameters reveals the impaired renal function or
acute renal failure. Hence the Madhana biravam did not induce any toxicity to the liver
and kidney. This was further confirmed by the histopathological assessment of these
organs.
· Acute toxicity study Rajarajeswaram tablet did not produce any toxic symptoms or
mortality at the dose level of 300 mg/kg/po in rats but it produce toxic symptoms and
mortality at the dose level of 2000 mg/kg/po in rats ,all three rats were died in 48 hours
and Observed of toxicity signs were lethargy, respiration rate reduced, nasal discharge,
mild ataxia, gait abnormal mild catalepsy, scratching, diarrhoea, water intake was more
and food intake was less, hair straightening, tremor and in necropsy spleen swelling,
kidney swelling ,heart normal, both lung reddish colour ,liver mild discolouration, both
lung congested, one lung more stasis seen and trachea normal, According to toxic class
method (OECD – 423 guidelines) theLD 50 dose of 500 mg/kg and above is categorized
as (X ‘unclassified).
· 28 days repeated oral dose toxicity study
· From the observation of the 28 days repeated oral dose study of Rajarajeswaram at the
dose of 3.96mg,19.8mg and 39.6 mg did not produce any significant changes in the body
weight, food and water intake, No mortality was observed on 1st, 2nd, 3rd and 4th week
in both male and female animals of Group I, Group II and Group III and IV. Generally
changes in body weight have been used to access the course of the disease and the
response to the therapy of drugs and also they indicate the adverse effects of drugs. No
significant changes were observed in the haematological parameters like Hb, RBC, WBC,
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clotting time and differential leucocyte counts for Rajarajeswaram treated groups shows
the levels of blood glucose, cholesterol, BUN, creatinine respectively. There were no
significant changes in any of the hematological parameters in Rajarajeswaram treated
group compared with the control groups. The blood glucose level, which remained
constant in all the groups of animals, shows the normoglycemic activity of the
Rajarajeswaram. Determination of BUN and serum creatinine shows that the
Rajarajeswaram did not produce any renal dysfunction, as increase in the above
parameters reveals the impaired renal function or acute renal failure. AST, ALT, ALP and
total bilirubin are good indices of liver function indicate that there were no significant
changes in the enzyme levels, when compared with the control animals. Hence the
Rajarajeswaram did not induce any toxicity to the liver and kidney. Determination of
kidney function tests shows that the did not produce any renal dysfunction, as increase in
the above parameters reveals the impaired renal function or acute renal failure. Hence the
Rajarajeswaram did not induce any toxicity to the liver and kidney. This was further
confirmed by the histopathological assessment of these organs.
Pharmacological study
· The pharmacological study suggest that trial drug may be effective against human
generalized tonic-clonic seizures. The Raja Rajeswaram in all doses does not protect
animals from seizures but duration of hind leg extension was slightly reduced
insignificantly P> 0.05 even at a dose level of 200 mg/kg. The rate of protection was very
significant at the entire Madhana Biravam treated groups when compared to control.
The observation in the present study indicated that the Madhana Biravam was without
any lethal effect in a dose upto 5 g/kg and the present results indicate that the test drugs
exhibited a significant dose dependent protection against electrically induced seizure.
· From the clinical study and statistical analysis proved that the trial drugs Rajarajeswaram
and Madhana biravam is statistically significant response in valippu(Epilepsy).
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SUMMARY
· Siddha literatures were revived and collected in support of Rajarajeswaram and
Madhanabiravam for valippu(Epilepsy)and the chosen trial drugs.
· The trial drugs Rajarajeswaram and Madhanabiravam were prepared as per the
standard operative procedures.
· The Physio chemical analysis, FTIR and SEM analysis were carried out and
results were obtained.
· Rajarajeswaram and Madhanabiravam was screened for safety (acute- toxicity,
28 days repeated dose toxicity) and efficacy (Anti -convulsant activity) was carried out as
per standard methods. The Madhanabiravam was considered to be safe. No mortality,
morbidity or adverse changes in the general behaviors in acute toxicity studies. No
alterations were observed in haemotological, biochemical parameters and
histopathological changes in 28 days repeated oral dose toxicity studies. This shows the
drug can be used for long-term administration. But Rajarajeswaram produce toxic
symptoms and mortality at the dose level of 2000 mg/kg/po in rats ,all three rats were
died in 48 hours and Observed of toxicity signs in acute toxicity studies. No alterations
were observed in haemotological, biochemical parameters and histopathological changes
in 28 days repeated oral dose toxicity studies.
· The anti-convulsant activity of Raja Rajeswaram in all doses does not protect
animals from seizures but duration of hindleg extension was slightly reduced
insignificantly P> 0.05 even at a dose level of 200 mg/kg. The rate of protection was very
significant at the entire Madhana Biravam treated groups when compared to control.
· After obtaining the consent from the patients for the study, the patients were
selected from the outpatient department of National Institute of Siddha,Chennai. The trial
drug Rajarajeswaram and Madhanabiravam were administrated to patients those were
chosen according to the selection criteria. The patients were carefully observed in regular
visit and prognoses were sincerely documented. The trial drug Madhanabiravam was able
to relive the clinical symptoms of the patients. But compare to Madhanabiravam the trial
drug Rajarajeswaram was less in relive the clinical symptoms and some patients had
complained drowsiness and less appetite in trial drug Rajarajeswaram and no adverse
were observed.
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CONCLUSION
The literature evidence, chemical analysis, the toxicological and pharmacological studies
and the observation of the clinical studies shows the trial drug Madhana Biravam may be
considered as a source in Siddha for therapeutic uses on epilepsy. The Madhana Biravam
possess good anti-convulsant activity (500mg)but Raja Rajeswaram have shown
moderate activity even at higher dose(200mg) used in this study. Further research is
necessary to determine the components involved and their mechanism of action in
bringing about the desirable pharmacological effects.
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